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CHAPTER I
INTRODUCTION
Intestinal epithelium structure
 The mammalian small intestine is a polarized organ with an inner layer facing 
the lumen and its contents, and an outer layer anchored by mesentery in the abdominal 
cavity. Because the lumen of the digestive tract is essentially open to the external 
environment, intestinal tissue must function not only as an absorptive surface but also 
as a defense against external insults, blocking translocation of harmful substances  into 
circulation or the abdominal cavity. Structurally, the small intestine is comprised of four 
primary layers, with the mucosa at the interface between lumen and tissue, followed by 
the submucosa, muscularis propria, and the serosa. The mucosa is subdivided into an 
epithelium, lamina propria, and muscularis mucosa (Fig. 1-1A) (Rao and Wang, 2010). 
Folds in the epithelium form crypts and villi, which provide increased surface area for 
absorption. Stem cells  reside at the base of the crypt and divide asymmetrically, 
maintaining the epithelium through daughter cell differentiation into absorptive 
enterocytes, mucus-secreting goblet cells, hormone-secreting enteroendocrine cells, 
and anti-microbial paneth cells (Fig. 1-1B) (Barker et al., 2008).
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Immune functions of the intestinal epithelial layer
 Because the intestinal epithelium is in direct contact with the lumenal 
environment, it forms a barrier that allows for selective absorption of nutrients while 
preventing entry of pathogens and toxins into systemic circulation. Most immune cells, 
such as dendritic cells, are primarily found in the lamina propria. Dendritic cells  extend 
protrusions through the epithelium to reach the lumenal surface and sample bacteria 
(Rescigno et al., 2001). They also form tight junctions  to maintain continuity with 
surrounding enterocytes and prevent unwanted bacterial translocation to the underlying 
tissue (Rescigno et al., 2001). Intraepithelial lymphocytes (IEL) are integrated with the 
epithelium. These cells  include specialized T-cells, and mediate downstream immune 
responses via cytokine secretion and indirect activation of B-Cells (Cheroutre, 2005).
 Non-immune cells within the epithelium, some of which are significantly more 
abundant than IELs, also play a notable role in host defense. Mucus produced by goblet 
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Figure 1-1: Intestinal architecture and epithelial cell types
cells provides a coating across  the epithelium to help inhibit bacterial interaction with the 
epithelial surface (McGuckin et al., 2011). Under normal conditions microbes are almost 
entirely excluded from reaching the inner of two mucus layers, providing spatial 
separation between potential pathogens and host tissue (Johansson et al., 2008; 
Johansson et al., 2011). Additionally, anti-microbial peptides (AMP) secreted by Paneth 
cells in the crypts  help maintain crypt sterility (Ouellette, 1999). AMPs are also 
integrated into the mucus  layer along the length of the villus, where they prevent enteric 
infection and regulate the gut bacterial population (Meyer-Hoffert et al., 2008; Salzman 
et al., 2010). Enterocytes also play several roles in immunity, discussed further below. 
Enterocytes and the brush border in host defense
 Enterocytes are the majority cell type of the intestinal epithelium and play a 
significant role in immune function. The apical and basolateral surfaces of these 
polarized cells are separated by tight junctions, which, along with adherens  junctions 
and desmosomes, link each enterocyte to its neighbor near the apex of the cell. 
Junctions are comprised of four groups of proteins (occludin, claudins, junction-
adhesion molecules, and Coxsackievirus and Adenovirus  Receptor proteins), and are 
critical for maintaining the integrity of the intestinal epithelial layer. Any disruptions in the 
tight junctions can lead to aberrant water flux or translocation of toxic molecules  or 
organisms (Guttman and Finlay, 2009). Such disruptions frequently occur during 
intestinal infection; pathogen-induced separation of several junctional proteins from the 
lateral cell membrane leads to fluid efflux and severe diarrhea (Guttman and Finlay, 
2009). Injection of certain bacterial effectors  leads to altered dynamics of junctional 
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actin, which allows for redistribution of tight junction proteins to the sites of bacterial 
attachment on the apical surface (Peralta-Ramirez et al., 2008).
 Apical to tight junctions of the enterocytes is  an array of actin-based protrusions 
called microvilli (Mooseker, 1985). Tightly packed in a hexagonal array called the brush 
border, these organelles are enriched in enzymes, transporters, and host defense 
molecules. Importantly, they significantly increase available absorptive surface area 
(Louvard et al., 1992). Each microvillus is  comprised of 20-30 parallel actin filaments 
supporting the overlying plasma membrane (Mooseker and Tilney, 1975). The core 
microvillar actin bundles are anchored in the terminal web, a sub-apical meshwork of 
keratin, spectrin, myosin-2, and plastin (Bretscher and Weber, 1978; Grimm-Gunter et 
al., 2009). Heteromeric complexes of protocadherin-24 (PCDH24) and mucin-like 
protocadherin (MLPCDH) link the distal tips of microvilli; this interaction is critical for 
normal development of a brush border and for regulating microvillar packing and length 
(Fig. 1-2) (Crawley et al, unpublished data).
 Within the microvillus, core actin filaments are bundled by villin, fimbrin, and, to a 
lesser extent, espin (Fig. 1-2) (Bretscher and Weber, 1979, 1980; Bretscher, 1981; 
Bartles et al., 1998). Espin cross-linking induces significant elongation of microvillar 
actin filaments by slightly altering the rate of plus-end polymerization (Loomis  et al., 
2003). In cell culture models, espin-stabilized actin can be leveraged for microscopy 
studies, providing improved visualization by elongating microvilli (Loomis et al., 2003). 
Villin both severs and bundles  actin, in a Ca2+ and phospho-dependent manner, making 
it an important molecule for remodeling of the brush border following damage to the 
enterocyte (Ferrary et al., 1999; Khurana and George, 2008). Fimbrin, also known as 
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plastin-1, cross-links microvillar actin bundles within the microvillus  and anchors them to 
the terminal web (Bretscher and Weber, 1980; Grimm-Gunter et al., 2009).
 
 Linking the parallel actin bundles to the overlying plasma membrane are lateral 
bridges comprised of the motor protein myosin-1a (myo1a) and the actin-bundling 
protein ezrin  (Fig. 1-2) (Mooseker and Tilney, 1975; Matsudaira and Burgess, 1979; 
Sato et al., 1992; Tyska et al., 2005). myo1a is comprised of an N-terminal motor 
domain that binds actin and hydrolyzes ATP, an alpha helical, force-transducing neck 
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Figure 1-2: Protein composition of the enterocyte microvillus
*Not all components shown
domain that is  rigidified by binding calmodulin molecules in a Ca2+-dependent manner, 
and a C-terminal tail domain that binds plasma membrane (Mooseker and Cheney, 
1995). Studies  on other class-I myosins has demonstrated load sensitivity; duty ratio - 
the proportion of the total ATP cycle a motor spends bound to actin - increases when the 
molecule is under mechanical strain (Laakso et al., 2008). It is possible that myo1a 
could exhibit similar force sensitivity, which would increase the time each molecule 
spends as a rigid cross-linker in the microvillus. Additionally, by acting in ensemble 
myo1a molecules effectively increase the population duty ratio (De La Cruz and Ostap, 
2004). Work in our lab has clarified the importance of myo1a for maintaining microvillar 
structure. In myo1a knockout (KO) brush borders membrane tension decreases 
significantly, a result which explains herniations observed in vivo (Tyska et al., 2005; 
Nambiar et al., 2009). Other characteristics and functions of myo1a are discussed 
below.
 Enterocytes also express several transmembrane mucins that localize to 
microvilli and form a glycocalyx that aids in defense against pathogens  (McGuckin et al., 
2011). Additionally, low levels  of toll-like receptors (TLRs) on the apical membrane allow 
enterocytes to activate immune signaling pathways. TLRs constitute one of the primary 
receptor families used by host cells to respond to environmental and pathogen-derived 
toxins. Eleven mammalian TLRs have been identified, and at least six respond to 
bacterial molecules (Akira and Takeda, 2004). In particular, TLR-4 acts as a receptor for 
lipopolysaccharide (LPS), a toxic compound produced by Gram-negative bacteria 
(Poltorak et al., 1998; Tapping et al., 2000). LPS binds TLR-4 and its co-receptor MD-2. 
Upon LPS binding, TLR-4 then binds the intracellular adaptor protein MyD88. In the 
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absence of TLR-4 activation, the NF-kB transcriptional complex is sequestered in the 
cytoplasm by the inhibitor of nuclear factor-kB (IkB) complex. Upon initiation of LPS-
induced signaling, a series steps involving the recruitment, phosphorylation/activation, 
and degradation of several intermediate proteins and complexes lead to the 
phosphorylation of IkB and subsequent targeting for its ubiquitylation and degradation. 
NF-kB is then released, translocates to the nucleus, and transcribes its target genes 
(Fig. 1-3) (Akira and Takeda, 2004; Ghosh and Hayden, 2008). In inflamed tissues, NF-
kB activation is correlated with increased levels of interleukins and tumor necrosis  factor 
(TNF) and recruitment of immune cells (Li and Verma, 2002; Akira and Takeda, 2004; 
Wullaert et al., 2011).
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Figure 1-3: TLR-4 mediated activation of the NF-kB inflammatory pathway
  Activation of NF-kB has the potential to become a positive feedback loop: 
cytokines controlled by NF-kB are expressed and released, leading to further TLR-
mediated NF-kB signaling. Therefore, the pathways involved must be tightly regulated 
to prevent unchecked inflammatory responses, such as the infamous “cytokine storm” 
associated with some viral and bacterial infections (Tisoncik et al., 2012). Investigators 
have found that under homeostasis, intestinal epithelial cells  in culture express very low 
levels  of TLR-4 on their apical surfaces, which likely prevents excessive inflammatory 
signaling (Abreu et al., 2001).
Microvillar vesicle shedding
 Myo1a is not simply a static linker in microvilli. In the absence of nucleotide, the 
motor exhibits a high affinity for actin, whereas ATP binding releases the motor 
(Howard, 2001). In a two-step process, hydrolysis of ATP and release of Pi, then release 
of ADP, conformational changes occur that displaces the motor relative to the rest of the 
molecule (Veigel et al., 1999; Howard, 2001). In isolated brush borders, addition of 1mM 
ATP induced the rapid translocation of membrane towards the tips  of microvilli, i.e. 
towards the plus ends of the parallel actin bundles. (McConnell and Tyska, 2007). In 
contrast, brush borders isolated from myo1a KO mice do not exhibit membrane 
translocation, demonstrating that this motor is capable of exerting force on microvillar 
membrane (McConnell and Tyska, 2007).
 As microvillar membrane reaches the distal ends of the underlying actin bundles, 
it is  released as small vesicles into solution (McConnell and Tyska, 2007). Remarkably, 
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these vesicles  can be isolated from small intestine lumenal contents in vivo; the number 
of vesicles found in myo1a KO mice is greatly reduced and the variability in size 
increases (McConnell et al., 2009). The finding that lumenal vesicle (LV) shedding is 
dependent on myo1a motor activity suggests these organelles  are released in a 
controlled manner, indicating a regulated physiological function for LVs. Further 
proteomic and biochemical analysis revealed that LVs are enriched in a subset of 
microvillar proteins, including intestinal alkaline phosphatase (IAP) and the membrane 
binding protein annexin-13 (A13), this specific enrichment is  lost in myo1a KO LVs 
(McConnell et al., 2009). Although the exact mechanism of LV shedding remains 
unclear, it is likely due in large part to translocation of membrane by myo1a. A sub-
population of the motor protein may also help to segregate microvillar proteins. FRAP 
studies in microvilli showed that ~20% of the intra-microvillar myo1a population has a 
slow rate of turnover, approximately the same percentage as that bound to microvillar 
lipid rafts  containing the digestive enzyme sucrase isomaltase (SI) (Tyska and 
Mooseker, 2002, 2004). This population of myo1a may immobilize SI-containing rafts, 
allowing for enrichment of IAP at distal tips.
 LV shedding is regulated by myo1a, but is also likely supported by the 
composition and curvature of microvillar membrane. Microvillar plasma membrane is 
unique in that it consists of largely stable lipid rafts, sometimes referred to as “super 
rafts” (Danielsen and Hansen, 2003). Distinct raft populations exist at the base and tip 
of a microvillus, but in general the high concentrations  of cholesterol and sphingolipids 
may promote and help stabilize the extreme membrane curvature found at both ends of 
the protrusion (Danielsen and Hansen, 2003). Furthermore, maintaining this  high 
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curvature is conducive for membrane scission events in the form of budding (from the 
tips) or endocytosis (at the base). Lipid microdomains recruit GPI-anchored proteins 
including IAP, as  well as some transmembrane proteins such as SI (Tyska and 
Mooseker, 2004). Cholesterol concentration increases along the length of a microvillus, 
which likely promotes  a similar gradient of raft associated proteins (Fig. 1-4). Further 
sorting at the distal tips of microvilli must be involved in producing the unique protein 
composition of LVs, where IAP and A13 are highly enriched, and myo1a and SI are 
excluded. A population of myo1a associates with SI-containing lipid rafts along the 
microvillar axis (Tyska and Mooseker, 2004); differences between the membrane lipid 
composition along the axis  and the highly curved microvillar tip might exclude SI and the 
motor while providing an environment conducive to GPI-anchored IAP.
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Figure 1-4: Gradient of lipid raft-associated molecules along the microvillar axis
Immunofluorescence of mouse small  intestinal tissue shows that IAP is enriched at the distal tips of 
microvilli. This is likely regulated by cholesterol, which is a key component of lipid rafts and forms a 
gradient along the microvillar axis. The chart shows the gradients of IAP and cholesterol  signal, 
increasing from just above the terminal web to pre-LV buds distal to the ends of the actin bundles.
Intestinal Alkaline Phosphatase
 IAP is  one of four alkaline phosphatase isozymes expressed in humans, along 
with liver/bone/kidney, or tissue non-specific AP (TNAP), placental AP (PLAP), and a 
minor form called placental-like AP (McKenna et al., 1979; Harris, 1990). Collectively, 
these enzymes dephosphorylate a wide range of substrates, with known function in 
processes ranging from bone formation, to fat absorption, to detoxification of bacterial 
products. APs function as dimers (Hoylaerts  et al., 1997), each monomer requiring two 
Zn2+ and one Mg2+ ion (Millan, 2006). A glycosylphosphatidylinositol (GPI) anchor 
tethers the enzymatic ectodomain to the membrane and helps localize IAP to lipid rafts, 
a feature which likely leads  to enrichment at the distal tips of microvilli (Lowe et al., 
1990; McConnell et al., 2009).
 Biochemical studies  revealed that purified IAP, as its name suggests, functions 
most effectively at high pH in experimental conditions. In vitro analysis of both purified 
soluble enzyme and IAP bound to isolated membrane vesicles  demonstrated a maximal 
activity above pH 9.5 (Chappelet-Tordo et al., 1974). Though intestinal pH increases 
along the length of the small bowel, from < 6.5 in the duodenum to > 7.4 in the distal 
ileum, it never reaches the apparent optimum for IAP activity (Fallingborg, 1999). 
Intriguingly, Chappelet-Tordo et al pointed out that Vm of the membrane-bound form of 
IAP is reached at a lower pH than that of the soluble enzyme (1974). The authors also 
find that IAP has a relatively low Km of IAP at pH < 8.0 (such as that found in the distal 
small intestine), which when taken together with high concentrations of phosphate-
containing substrates in the intestinal lumen, IAP “most probably works in Vm conditions 
in vivo” (Chappelet-Tordo et al., 1974). Despite this  analysis, along with later work 
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showing alkaline phosphatase to be an incredibly efficient enzyme in vitro (Simopoulos 
and Jencks, 1994), the field was unable to conclusively determine the in vivo function 
for IAP for another twenty years.
 A physiological function for IAP was elucidated in 1997, when Poelstra et al. 
tested bacterial lipopolysaccharide (LPS, or endotoxin), a molecule with multiple 
phosphate groups, as  a substrate for IAP (Poelstra et al., 1997). This work revealed that 
IAP not only liberates  phosphate from LPS, but it does so at physiological pH. Although 
this  document will focus on LPS, other recent work has expanded the catalogue of 
known IAP substrates to include bacterial toxins  such as flagellin and CpG DNA (Chen 
et al., 2010b).
 On a molecular level, LPS binds TLR-4, initiating the signaling cascade 
described above (Fig. 1-3) (Tapping et al., 2000; Akira and Takeda, 2004). 
Dephosphorlyation of LPS by IAP prevents activation of the NF-kB pathway (Goldberg 
et al., 2008). Inhibition of endogenous IAP increases serum LPS levels and mortality in 
rats infected with E. coli or orally administered LPS (Poelstra et al., 1997; Koyama et al., 
2002). Studies in zebrafish showed that IAP expression is turned on in the larval stage 
three days post-fertilization; this time point corresponds with the opening of the mouth 
and resultant introduction of bacteria into the digestive tract (Bates  et al., 2006). 
Similarly, administration of LPS is  sufficient to induce IAP expression, and inhibition or 
morpholino-mediated knockdown of endogenously expressed IAP led to hypersensitivity 
to LPS (Bates et al., 2006; Bates et al., 2007). IAP KO mice are actually less 
susceptible to treatment with soluble LPS than WT, and although these animals have no 
overt phenotype under normal conditions, pathogenic bacteria more readily translocate 
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when compared to WT animals (Goldberg et al., 2008). Furthermore, the composition of 
the IAP-KO intestinal bacterial population is altered relative to that of WT (Chen et al., 
2010a; Malo et al., 2010).
 Together, these studies  led to a model where the introduction of intestinal 
bacteria stimulates the expression of IAP, which functions as a host defense factor to 
dephosphorylate (and thereby detoxify) LPS. Detoxification, in turn, reduces the 
proinflammatory potential of the intestinal microbiome, reducing inflammatory signaling 
and immune responses  (Bates et al., 2007). In IAP KO animals, the chronically high 
levels  of proinflammatory molecules that retain their toxicity is  thought to lead to 
overstimulation of inflammatory signaling cascades and subsequent downregulation of 
TLR-4 as a tolerance mechanism (Chen et al., 2010a). Not only does  IAP detoxify 
bacterial products, but it also helps prevent acute overgrowth of pathogens by aiding in 
maintenance of a healthy bacterial population (Malo et al., 2010). In this finely balanced 
system, intestinal bacteria induce the host-defense enzyme IAP, which in turn regulates 
the microbiome. Disease states such as colitis have been correlated with perturbations 
on either side of the equation [(Mazmanian et al., 2008; Tuin et al., 2009), reviewed by 
(Packey and Sartor, 2009)]. Although most IAP studies focus on the soluble enzyme, 
work showing its enrichment on LVs raises the intriguing possibility that vesicles serve 
to deliver IAP to the intestinal lumen, concentrating its  activity as a host defense factor 
(McConnell et al., 2009).
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Intestinal Microbiome
 Due to the enormous surface area presented by the small intestine, as well as its 
exclusive role in nutrient absorption, it is  important to understand the interplay between 
this  organ and the microbiome. “Microbiome” refers to the collective genome of resident 
microbes, “microbiota” refers  to the microbial population. A stunning ~15,000 species of 
bacteria reside in the human intestine, with a total bacterial load of ~1014 bacterial cells 
(although it should be noted that most studies have put the number of bacterial species 
much lower, closer to 1,000) (Savage, 1977; Frank et al., 2007; Claesson et al., 2009). 
The vast majority of these are found in the large bowel, where the concentration 
approaches 1012 bacteria per gram of intestinal contents (Sartor, 2008). However, we 
have estimated that at least 108 bacteria are present in the small intestine (Shifrin and 
Tyska, 2012). Bacteria in the small intestine are required both to aid in digestion and to 
protect against infection from pathogens acquired from the environment as well as 
native, opportunistic pathogens already in the gut (Backhed et al., 2004; Backhed et al., 
2005). The entire relationship between host and microbiome is one of finely tuned 
cross-talk; bacteria and bacterial genes are so integral to the normal functioning of the 
human body that some investigators suggest that humans are “supraorganisms” 
comprised of homo sapiens and its resident microbes (Gill et al., 2006). Significant 
variation exists between the microbiota of individuals at the level of genus and species. 
However, under normal conditions the core bacterial population is relatively consistent 
at the higher phylogenetic levels, consisting of ~30-50% Bacteroidetes, ~50-70% 
Firmicutes, and small contributions from other phyla including Actinobacteria and 
Proteobacteria (Eckburg et al., 2005; Peterson et al., 2008). Furthermore, the functional 
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conservation of the microbiome is quite high; i.e. healthy individuals exhibit similar 
microbial genetic profiles, even when the microbial species carrying those genes vary 
(Qin et al., 2010; Consortium, 2012). 
 Gut bacteria are necessary for normal development of intestinal architecture; the 
intestines of germ-free zebrafish remain in an immature state with impaired epithelial 
differentiation. These animals have minimal IAP activity and reduced numbers  of goblet 
and enteroendocrine secretory cells, defects which can be reversed by the introduction 
of a normal microbiota (Bates et al., 2006). Intestinal bacteria also play a critical role in 
stimulating development of the host immune system (Falk et al., 1998; Hooper et al., 
1998; Round and Mazmanian, 2009; Sommer and Backhed, 2013). Differentiation of 
TH17 helper T-cells  is regulated by an unusual microbe called segmented filamentous 
bacteria (SFB), which under normal conditions is the only bacterial species in direct 
contact with host epithelia (Ivanov et al., 2009). More generally, isolated lymphoid 
follicles, tertiary lymphoid structures that serve as “outposts” of immune defense in the 
intestinal tract, show lower levels of maturation in germ-free mice. Similarly, these 
animals have reduced numbers of Peyer’s patches (Round and Mazmanian, 2009). 
These studies show that a normal gut microbiome is important for inducing maturation 
of the mammalian immune system, which in turn allows the host to regulate the 
microbiome and prevent overgrowth of species  that could be harmful to both the host 
and the commensal bacterial population.
 While the microbial population helps to regulate the host physiology, the reverse 
is  also true. For example, secretion of α-defensin by Paneth cells  is  important not only 
for preventing pathogenic infection, but also for maintaining normal gut bacterial 
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populations (Salzman et al., 2010). Expression of the human α-defensin gene DEFA5 in 
mice causes inversion of the ratio between Firmicutes and Bacteroidetes and reduction 
in the number of SFB. In turn, shifts in the microbiome alter the mucosal inflammatory 
response, measured by a drop in the number of TH17 T-cells (Salzman et al., 2010). 
IAP KO mice have decreased overall numbers of colonic bacteria, and while the relative 
abundance of both Firmicutes and Bacteroidetes remains statistically similar, shifts at 
lower phylogenetic levels are observed in the form of an increase in the class Clostridia 
(phylum Firmicutes) and the family Helicobacteraceae (phylum Proteobacteria) (Malo et 
al., 2010). Though outside the scope of this  discussion, it is  important to note that 
factors such as diet, environment, and genetics are all factors in determining an 
individual’s specific microbiota (Lozupone et al., 2012).
 Perturbations to intestinal physiology, such as infection, inflammatory bowel 
disease, and obesity, are also correlated with significant shifts in the microbiota (Ley et 
al., 2005; Peterson et al., 2008; Turnbaugh et al., 2009). In mice infected with the 
enteric pathogen Citrobacter rodentium, relative abundance of Bacteroidetes in the 
colon decreases dramatically (Lupp et al., 2007). In the same study, investigators 
demonstrated that a genetic predisposition towards  inflammation allows for significant 
increases in the percentage of the family Enterobacteriaceae, part of the phylum 
Proteobacteria, which includes  E. coli species (Lupp et al., 2007). Consistent with this, 
Crohn’s disease patients also exhibit increased colonization by the E. coli population, 
including the pathogenic adherent/invasive E. coli (Packey and Sartor, 2009). In human 
patients with bacterial translocation to mesenteric lymph nodes and systemic circulation 
following laparotomy, E. coli accounts for the majority (67%) of bacterial species 
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cultured (O'Boyle et al., 1998). This study was carried out prior to the common 
application of culture-independent methods for investigating bacterial populations, and 
therefore does not take into account what is now known to be a huge population of 
nonculturable bacteria. However, it is consistent with later analyses using molecular 
tools and points to E. coli as  both a marker of defective barrier function as well as an 
opportunistic pathogen with the capacity to perturb intestinal homeostasis. Furthermore, 
within this species, several strains  that are primary enteric pathogens cause disease in 
otherwise healthy individuals.
Enteropathogenic E. coli
 Over 750,000 children under the age of five die of diarrhea-related dehydration 
each year (World Health Organization). Most common in developing regions, several 
types of bacteria, including a group of virulent E. coli strains found in contaminated food 
or water, lead to outbreaks  of diarrheal diseases (Evans and Evans, 1996). Among 
these is Enteropathogenic E. Coli (EPEC), which attaches to the apical surface of 
enterocytes. EPEC infection ultimately results in severe disruption of tight junctions, 
which causes massive fluid and ion imbalances across the intestinal epithelial barrier, 
and subsequent diarrhea (Guttman and Finlay, 2009).
 EPEC is  called an attaching/effacing (A/E) pathogen. It remains  on the 
extracellular surface of a host cell, co-opting host cell machinery to produce an actin-
rich pedestal that anchors the bacterium while allowing it to move laterally across  the 
cell surface (Stevens  et al., 2006). Many of the highly conserved bacterial factors 
involved in this process are encoded by a pathogenicity island called the locus of 
enterocyte effacement (LEE), while several more non-LEE proteins involved in 
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pathogenicity vary between bacterial strains (Wong et al., 2011). Initial attachment of 
EPEC to the apical surface of an enterocyte is  mediated primarily by the bundle forming 
pilus (BFP), with a partially redundant role played by a component of the type III 
secretion system (T3SS) called EspA (Cleary et al., 2004). BFP are also critical for inter-
bacterial adhesion, helping EPEC form characteristic microcolonies, where multiple 
bacterial cells auto-aggregate on the cell surface in a process called localized 
adherence (Hicks et al., 1998). Upon contact, BFP filaments  retract, bringing the 
bacterium closer to the host cell surface and allowing the attachment process to 
proceed (Zahavi et al., 2011). Once the BFP has retracted, EPEC utilize the T3SS, a 
specialized “needle,” to inject virulence factors  into a host cell. It has been noted that 
direct injection of bacterial proteins allows an EPEC cell to gain direct access  to the host 
cytosol without having to utilize host cell endocytic pathways and retrotranslocation 
(Viswanathan et al., 2009). Multiple virulence factors are involved in this process; 
however, the primary pathway for intimate attachment and pedestal formation involves 
insertion of the bacterial protein Translocated Intimin Receptor (Tir) into the host cell 
membrane (Deibel et al., 1998). The outer membrane protein intimin (eae), a critical 
mediator of EPEC attachment and virulence, then binds and clusters Tir on the host cell 
surface and promotes phosphorylation of Tir at Y474 (Donnenberg et al., 1993; Kenny, 
1999; Liu et al., 1999). In fact, a short sequence of 12 C-terminal residues, including 
Y474, is  sufficient to induce the next step: binding of Tir to Nck (Campellone et al., 
2002). Nck binds N-WASP, activates the Arp2/3 actin nucleation complex, and results in 
the rapid polymerization of a dense, branched actin network under the bacterium 
(Campellone, 2010; Wong et al., 2011). Recent work has shown in HeLa cells that in 
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addition to branched actin, pedestals also contain a spectrin “cage” around the 
periphery (Ruetz et al., 2011; Ruetz et al., 2012). Spectrin may help to stabilize the actin 
network and link it to the plasma membrane (Ruetz et al., 2012). Ultimately, a pedestal 
comprised of a robust cytoskeletal network overlaid by the plasma membrane surrounds 
the bacterium on three sides, holding it in place on the extracellular surface and 
providing a secure attachment to allow for division and, over time, the formation of a 
microcolony of multiple EPEC cells. Microvilli surrounding the microcolony are 
destroyed during this process, leaving an area around the bacteria devoid of brush 
border and giving rise to  a cellular morphology termed the A/E lesion (Fig. 1-5).
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Figure 1-5: Tir and intimin mediate EPEC pedestal formation via the Arp2/3 pathway
 As the process of intimate EPEC attachment progresses, microvilli surrounding 
the bacteria elongate and orient toward the pathogen (Dean et al., 2006). Microvillar 
elongation has long been observed as part of the normal A/E process during EPEC 
infection (Bernet-Camard et al., 1996; Phillips  et al., 2000; Cleary et al., 2004; Shaw et 
al., 2005; Dean et al., 2013). The extended protrusions, often called microvillus-like 
processes (MLP), are thought to depend upon the LEE-encoded effector protein espF, 
and though not intimin-dependent, develop more slowly in Δintimin EPEC mutants 
(Frankel et al., 1998; Phillips  et al., 2000; Shaw et al., 2005). EspF putatively binds 
actin, N-WASP, and the actin-sequestering protein profilin (Weflen et al., 2009; Wong et 
al., 2011); consequently, EspF injected by EPEC disrupts tight junctions, most likely by 
sequestering actin-profilin complexes, thereby altering actin dynamics and endocytosis 
(Peralta-Ramirez et al., 2008). At the same time, an in vitro study showed that EspF 
promotes actin polymerization through its  interaction with N-WASP and a membrane-
cytoskeleton adaptor protein SNX9; this function is  likely used at sites of bacterial 
attachment to advance pedestal formation (Alto et al., 2007; Peralta-Ramirez et al., 
2008).
Summary
 Infection by enteric pathogens can be viewed as a tug-of-war. The innate 
immune system deploys constitutively active processes to prevent infection and 
maintain homeostasis. For example, mucins produce by goblet cells forms a thick layer 
to inhibit bacteria from reaching the epithelial surface, paneth cells  in the crypt secrete 
antimicrobial peptides (McGuckin et al., 2011), and tight junctions between cells in the 
epithelial layer prevent microbial translocation. Leukocytes in the gut recognize and 
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destroy pathogens and toxins, and when necessary activate signaling cascades to 
initiate a larger inflammatory response. As discussed above, the microbiota itself can be 
considered a defense mechanism by self-regulating and working in conjunction with the 
host to prevent overgrowth of opportunistic pathogens and/or invasion from primary 
pathogens normally excluded from the intestinal tract. Upon sensing the presence of a 
pathogen, host cells activate immune responses in order to clear the microbial threat 
and prevent systemic infection. Likewise, bacteria have developed mechanisms to 
subvert host immune function. Secreted EPEC toxins activate pro-inflammatory 
signaling by enterocytes and other cell types, while active infection by live EPEC to a 
certain extent actually leads to an attenuation of this process (Sharma et al., 2006). 
That is, the enterocyte responds defensively to bacterial toxins, but the bacteria itself 
can manipulate a host cell into limiting its  response. Beyond attenuating inflammation, 
pathogens alter other host cell processes, including limiting apoptosis as a mechanism 
to clear infected cells (Hausmann, 2010), and hijacking cytoskeletal pathways during 
intimate attachment.
 Because the brush border is the first contact point for pathogenic bacteria, I have 
chosen to focus on the role of this domain during the early infection process. Several 
aspects of host defense mediated by enterocytes have been discussed above. Our lab 
has demonstrated the presence of IAP-enriched vesicles in the intestinal lumen. 
Membrane-bound IAP at distal tips  of microvilli, the enrichment of this enzyme in LVs, 
and the highly regulated nature of LV shedding by the motor protein myo1a led us to 
investigate a possible novel role for these extracellular organelles in host defense. In 
the work described in Chapter IV, we characterize this novel function of LVs. We find 
21
that LV-bound IAP is catalytically active, and robustly dephosphorylates LPS from 
numerous bacterial sources. Removal of phosphate from LPS reduces the molecule’s 
toxicity; indeed, in cell culture, treatment of LPS from pathogenic E. coli reduces 
activation of the NF-kB pathway. Using two human intestinal epithelial cell lines, we 
show that LVs  inhibit EPEC attachment to host cells, reducing the ability of the bacteria 
to form intimate attachment. LVs also have a bactericidal effect; EPEC population 
growth is inhibited in overnight cultures in the presence of LVs. Finally, LV shedding is  a 
constitutive process, but can be increased in response to the presence of pathogens. 
Using western blot analysis, we show an increase in LV protein markers following 
addition of EPEC to intestinal epithelial cell culture. Consistent with previously published 
work showing that myo1a is critical for LV shedding (McConnell and Tyska, 2007; 
McConnell et al., 2009), we find that pathogen-stimulated LV shedding is dependent 
upon the functional motor protein. Together, this work demonstrates that LVs constitute 
a previously unknown aspect of innate immunity, potentially functioning in vivo in a 
multi-faceted manner to limit the proinflammatory potential of intestinal contents and 
inhibit bacterial infection.
 In the second part of my research, I focused on the effect a pathogenic bacteria 
has on the brush border by investigating how cellular actin is used by EPEC to form a 
pedestal. Although the signaling pathways and host cytoskeletal rearrangements that 
occur during intimate EPEC infection are well characterized, a significant gap in 
knowledge exists at the point of initial contact between bacterium and host cell. 
Tantalizing hints have been published previously, most notably the presence of MLPs 
relatively early in the infection process. These studies, though informative, have been 
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limited by the use of static readouts. To date, we are unaware of a true kinetic analysis 
of microvillar dynamics and pedestal formation utilizing live cell microscopy. We have 
attempted to address  this gap with a combination of live cell deconvolution imaging and 
scanning electron microscopy (SEM) of EPEC attachment to Caco-2BBE cells. We have 
found that during pedestal formation, apical “flow” appears to draw microvilli into the 
region of attachment, and that this  process  is at least in part dependent upon PCDH24. 
Consistent with previous work, we see microvillar elongation (i.e. the formation of MLPs) 
occuring during this process; MLPs are induced by EPEC and elongate towards the 
bacterial cell in a directed manner, cluster at their distal tips, and adhere to the 
bacterium. In cells expressing espin, a parallel actin bundling protein, we observe 
microvilli being incorporated into nascent pedestals, a finding that strongly suggests 
pedestals can be built by recycling of pre-formed actin structures. We therefore 
hypothesize that EPEC not only hijack Arp2/3 actin polymerization machinery, but also 
utilize the large pool of F-actin in the apical domain to form intimate attachments. In this 
model microvilli provide actin to the bacteria early in attachment; as the bundles are 
repurposed into pedestals, the microvilli are disassembled, leading to effacement at 
later stages. Our model is further supported by the observation that upon inhibition of 
the Arp2/3 complex, EPEC still induce the formation of pedestals. We believe this data 
represents a previously uncharacterized pathway by which EPEC subverts the apical 
domain of enterocytes in order to intimately adhere to the host cell.
 The studies described here provide a number of exciting new insights into 
interactions between host epithelia and pathogenic microbes, and give rise to new 
models of host defense in the mammalian gut mucosa.
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CHAPTER II
MATERIALS AND METHODS
Chapters III, IV
Isolation of native LVs
 All procedures involving animals  were carried out under the auspices of the 
Vanderbilt University Medical Center Institutional Animal Care and Use Committee. 
Lumenal vesicles were isolated from rat small intestines as described previously 
(McConnell et al., 2009), with the addition of ampicillin (50 µg/ml), kanamycin (30 µg/
ml), and tetracycline (50 µg/ml) to the 500 x g supernatants, the resuspended 100,000 x 
g pellet, and the LV-containing sucrose gradient fractions, to eliminate contaminating 
bacteria from native material. LV protein concentrations were determined by BCA assay. 
An average rat LV preparation produces 100-150 µg LVs/ml intestinal contents. 
However, this range likely represents  a low end estimate for the physiological 
concentration of LVs in the lumen for two reasons: (i) SEM of native rat small intestine 
shows that large numbers of LVs are caught in the mucous layer (unpublished 
observations), and (ii) LVs are likely cleared from the lumen via their direct interactions 
with lumenal bacteria (Fig. 3-1). Vesicles  in either of these two populations are not likely 
to be recovered during typical preparations. Thus, experiments were carried out using a 
maximum of 200 µg LVs/ml media (attachment, RelA translocation, and enzymatic 
assays). For growth assays, LVs were used at a concentration of 50 µg LVs/ml as 
higher concentrations impacted baseline OD600 readings.
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Phosphate release assays
 Malachite green (Sigma, St. Louis, MO) at 0.56 mM in ddH2O was mixed in a 3:1 
ratio with 4.2% ammonium molybdate (Sigma) in 4 N HCL (MG:AM solution). For LPS 
dephosphorylation assays, 100 µg/ml phenol-purified LPS (Sigma) ± 10 µg LVs or 0.1U 
IAP (Sigma) were incubated in 50 µl LV reaction buffer (1x TBS pH 8.1, 1 mM MgCl2, 
0.1 mM ZnCl) for 30 min at 37° C. A 500 µl volume of MG:AM solution was added to the 
reaction, and allowed to sit at room temperature for 1 min, after which the phosphate-
MG:AM reaction was quenched with 50 µl 34% sodium-citrate (Sigma) in ddH2O. 200 µl 
reactions were loaded into clear 96-well plates  and absorbance read on a BioTek plate 
reader at 650 nm. For kinetic assays, reaction volumes were increased to 400 µl, 25 µl 
samples were removed at 2 min intervals and added to 250 µl of MG:AM, and reactions 
were quenched at 1 min with 25 µl 34% Na-citrate.
FAVS analysis
 Intestinal flushate was passed through a coarse wire filter, followed by a 40 µm 
filter to remove large particulate matter. The resulting material was used for labeling and 
sorting. Material was blocked for 1 hr at 4° C with 2 % bovine serum albumin (BSA), and 
LVs were labeled with anti-IAP antibody (1:400; Sigma-Aldrich) and DiD (1:400; 
Invitrogen) for 1 hr at 4° C, pelleted at 100,000 g for 1 hr, washed in PBS, pelleted 
again, resuspended in PBS, and Alexa Fluor 488-conjugated goat anti–rabbit secondary 
antibody was added (1:400) for 1 hr at 4° C (Invitrogen). Bacteria were stained using 
DAPI (1:2000). FAVS was performed as  previously described (Cao et al., 2008) using a 
FACSAria II (BD) customized with forward scatter photomultiplier tube assembly, which 
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was initially calibrated using CS&T beads. Unstained and single-stained (anti-IAP only, 
DiD only, or DAPI only) vesicles were used to compensate spectral overlap, which in all 
cases was nominal. Multicolor stained particles  were gated for both IAP and DAPI, and 
signals pulse processed for doublet discrimination.
Cell culture and bacterial strains
 HT-29 and Caco-2BBE were grown in DMEM (Gibco) supplemented with 10% 
defined fetal bovine serum and 1 mM L-glutamine (Gibco) at 37° C, 5% CO2. Caco-2BBE 
cells were transfected with GFP-tagged myo1a-TH1 (Tyska and Mooseker, 2004) and 
maintained in selection media (growth media with 500 µg/ml G418). For RelA 
translocation assays, HT-29 cells were plated on coverslips and simultaneously 
transfected (Effectene, Qiagen) with GFP-RelA (Chen et al., 2001). Media was changed 
after 24 hrs and cells serum-starved in DMEM overnight prior to use. EPEC were grown 
overnight in Luria-Bertani broth with kanamycin, shaking at 225 rpm, 37° C. Shigella 
strains were grown similarly. Prior to use in attachment assays, overnight EPEC cultures 
were diluted and grown for 2 hrs in recovery media as described (Sharma et al., 2006).
Bacteria attachment and microvillar vesicle shedding assays
 For bacterial attachment assays, cells  were seeded on acid-washed coverslips in 
6-well dishes (TRP) or polycarbonate Transwell filters (Costar) differentiate for five-days 
post-confluency. Approximately 2x105 CFU EPEC ± i) 200 µg/ml LV, ii) 200 µg/ml fixed 
LV (15 min fixation in 4% paraformaldehyde [EMS]-PBS, then washed 3x by 
centrifugation at 100,000 x g in 1x TBS, resuspended to original volume in 1x TBS), iii) 2 
U/ml IAP, or iv) 200 µg/ml LV + 10 mM L-phe were added to coverslips in serum-free 
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DMEM. 6-well plates  were centrifuged for 5 min at 50 x g to accelerate contact between 
bacteria and the cell monolayer, then incubated for 3 hr at 37° C, 5% CO2. For RelA 
translocation assays, EPEC were used at ~2x107 CFU. Shedding assays  were carried 
out by seeding Caco-2BBE cells  or Caco-2BBE cells stably expressing EGFP-myo1a-TH1 
in T75 flasks, and growing until 7 days post-confluency. Prior to treatment, monolayers 
were washed with sterile PBS, then incubated with ~2x106 CFU live EPEC, EPEC 
heated at 95° C for 15 min, Shigella, or 10 µg/ml E. coli O55:B5 LPS diluted in serum-
free DMEM for 6 hr. Media was removed and centrifuged at 5,000 x g, 20,000 x g, and 
100,000 x g, with pellets from each step being resuspended in 1/100 the original volume 
to concentrate cellular material.
Western blots
 Samples were diluted with Laemmli sample buffer, heated at 100 C° for 5 min, 
and equal volumes loaded on a 4-12% Nu-Page gradient gel (Invitrogen). Proteins were 
transferred to nitrocellulose, which was subsequently blocked for 1 hr in 5% milk-PBS. 
Primary antibodies against IAP (Sigma), Annexin A13b (R&D) and actin (Sigma) were 
diluted 1:1000 in PBS containing 0.1% Tween-20 (PBS-T), and incubated with the 
membranes at room temperature for 1 hr. Membranes were washed in PBS-T, then 
incubated with donkey-anti-rabbit 800 or donkey-anti-goat 680 IRdye (Li-Cor) at 
1:10,000 for 30 min. Membranes  were again washed with PBS-T and imaged using a 
Li-Cor Odyssey infrared imaging system. Images of membrane scans were cropped and 
contrast adjusted using ImageJ version 1.45d (NIH).
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Electron microscopy
 Sample preparation and imaging for negative-stain TEM and SEM was carried 
out as described previously (McConnell et al., 2009). Negative-stain samples  were 
imaged on a Phillips CM12 TEM. Samples for SEM were imaged on a Hitachi S-4200 
cold field emission SEM.
Immunofluorescence labeling and confocal imaging
 Coverslips were fixed with 4% paraformaldehyde/PBS for 15 min, washed, and 
blocked for 1 hr in 5% BSA/PBS. For EPEC attachment assays, rabbit polyclonal anti-
IAP (Sigma) was diluted 1:200 and incubated on sample coverslips for 1 hr. Coverslips 
were then washed (3 x PBS) and treated for 30 min with goat-anti-rabbit secondary 
antibody (1:200) and phalloidin (1:200) to delineate pedestals and cell morphology. 
Because IAP was enriched at sites  of bacterial attachment even at very early stages of 
adherence, this marker and DAPI were used to count EPEC on the surface of 
monolayers. Clusters  of five or more EPEC organisms were counted as microcolonies. 
For RelA translocation assays, cells were only stained with phalloidin. Coverslips  were 
again washed (3 x PBS) and mounted on slides using ProLong Gold with DAPI 
(Invitrogen). Images were acquired using a Leica SP5 laser scanning confocal 
microscope (LSCM), and cropped and contrast adjusted using ImageJ version 1.45d. 
For RelA translocation assays, samples were imaged using a Nikon TiE inverted 
widefield microscope with Nikon Elements v.3.2. Mean intensities from the nucleus and 
cytoplasm in raw images were acquired using the “oval selection” and “measure” tools 
in ImageJ. Cytoplasmic:nuclear ratio was  calculated and cells with a ratio of ≤1.1 were 
counted as having nuclear translocation.
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Bacterial growth assays
 Native Gram-negative bacteria were isolated by streaking out serial dilutions of 
rat intestinal contents onto MacConkey agar; colonies were selected and grown in liquid 
culture overnight using LB media. Bacteria were grown in recovery medium (Sharma et 
al., 2006) for 2 hr and added at a concentration of ~2.5x104 CFU/ml, determined by 
streaking serial dilutions onto LB agar plates, into LB broth (for EPEC, including 50 µl 
ampicillin to prevent contamination). LVs were added at a concentration of 50 µl, or IAP 
at 5 U/ml. Reaction mixtures  of 200 µl were seeded in replicate in 96-well plates. OD600 
was determined by incubating plates at 37° C in a Synergy HT plate reader, shaking for 
60 sec prior to each reading at 10 min intervals. To determine viable CFU following 
overnight growth, samples  were diluted 1:100 and sonicated in a Branson 1510 water 
bath sonicator for 2 x 30 sec, then serially diluted to 1:100,000 and plated on LB agar 
plates with ampicillin. Plates were incubated overnight at 37° C then scanned and 
colonies counted on a GelCount system (Oxford Optronix). For stationary phase assays 
in depleted media, LVs were added to overnight EPEC cultures without changing media. 
For stationary phase assays in replenished media, overnight cultures were pelleted at 
800 x g for 3 min, then resuspended in the original volume of fresh LB.
16S rDNA analysis
 Diluted rat small intestine contents were streaked out on MacConkey agar plates 
and incubated at 37° C overnight. Colonies were picked and samples of each added to 
25 µl endotoxin-free H2O. Samples were heated at 95° C for 2 min to lyse bacteria, then 
centrifuged at 16,000 x g for 2 min. Supernatant was used as template for PCR, with 
Platinum PCR Supermix (Invitrogen) and the highly conserved primers 8F/1492R (Eden 
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et al., 1991; Schmidt and Relman, 1994). PCR reactions used a Eppendorf 
MasterCycler according to the following parameters: initial denaturing at 94° C for 3 min, 
then 30 cycles  of 94° for 30 sec, 48° for 45 sec, 72° for 30 sec, and a final extension at 
72° for 10 min. Sequencing was carried out at the Vanderbilt University Medical Center 
DNA sequencing core, using the 907R primer (Wen et al., 2008); sequences were 
uploaded to the Ribosomal Database Project (RDP) and identification was made to the 
genus level (Wang et al., 2007).
Tissue preparation and analysis
 Small intestines  from WT and myo1a KO 129 SVJ1 or FVB mice were collected, 
flushed with warm saline (0.9% W/V NaCl, 0.2% Na-Azide, 2mM Imidazole pH 7.2), 
filled with 4% PFA (EMS), and the ends were clamped and fixed at room temperature 
for 15 min. Intestines were opened longitudinally and rolled. For frozen embedding, rolls 
were fixed 4% PFA for 2 hr, and incubated in 1 M sucrose in TBS (150 mM NaCl and 50 
mM Tris, pH 8.0) overnight at 4° C. Tissue was embedded in OCT, frozen, and 20 µm-
thick transverse sections were cut on a cryostat (Leica). Sections were stained using 
anti-IAP (1:200; Sigma-Aldrich) and Alexa Fluor 488 secondary (1:200), 568 phalloidin 
(1:200; Invitrogen). Fillipin was used at 50 µg/ml. Images were acquired with a Leica 
TCS SP5 LSCM or an Olympus FV1000 LSCM and processed using ImageJ. Villar 
length measurements were taken using the freehand line tool in ImageJ, and the 
number of IAP-enriched puncta counted. For IAP and fillipin gradients, 5 µm lines were 
drawn from just below the terminal web to just past the end of the brush border, and 
intensity profiles were plotted for each channel.
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 For histological analysis, rolls were fixed in 10% formalin overnight and submitted 
to the Vanderbilt Immunohistochemistry Core for paraffin embedding, sectioning, and 
staining. Sections were stained with hematoxylin & eosin for general histological 
analysis, or Periodic acid-Schiff and Alcian blue staining to label goblet cells. Images 
were acquired with a QImaging Micropublisher 3.3 RTV, and enhanced and cropped 
using ImageJ 1.45d. Goblet cells  were counted manually on a per villus basis along the 
length of the intestine.
ELISA assays
 WT and myo1a KO small intestines were removed and flushed with saline. The 
ileum was then cut longitudinally and the mucosa scraped into RIPA buffer with 
Pefabloc. Samples were homogenized in a glass dounce and centrifuged at 15,000 x g. 
Cytokine levels in the resulting supernatant was probed using R&D Quantikine kits  for 
IL-6 and TNF-α.
Chapters VI, VII
Cell culture and shRNA knockdown
 Caco-2BBE cells were grown as described above; HeLa cells were grown in 
DMEM (Gibco) supplemented with 10% defined fetal bovine serum. EPEC cultures 
were grown as described above. For PCDH24 knockdown, shRNA plasmids 
(OpenBiosystems) were expressed in DH5-α bacterial cells and purified using Qiagen 
maxiprep kits. HEK293FT cells were grown in DMEM with 10% FBS, 2mM L-Glutamine, 
and 1% MEM non-essential amino acids solution. Cells  were transfected 6 hrs after 
plating with PCDH24 or scramble shRNA using FuGene6, according to manufacturers 
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instructions (Promega). Virus was  harvested two days  after transfection, concentrated, 
and stored overnight. Concentrated virus was centrifuged and resuspended in DMEM, 
mixed with Polybrene, and added to Caco-2BBE cells. Transfected cells were selected for 
using puromycin, and knockdown was confirmed by western blotting.
Attachment assays and sample processing for confocal and SEM imaging
 For attachment assays, Caco-2BBE cells were grown on glass coverslips or 
collagen-coated Transwell filters as described above for 14 days post-confluency. 
Bacteria at 2x105 CFU/ml were added to monolayers and incubated for 1 or 3 hrs. To 
accelerate bacterial contact in order to investigate the time course of microvillar 
elongation, cells and bacteria were centrifuged for 3 min at 250 x g, then incubated for 
15 min. Filters were fixed and processed for SEM as described above, and imaged 
using and FEI Quanta 250 ESEM. Coverslips were fixed and stained for 
immunofluorescence as described above, with goat polyclonal anti-Lipid A used to label 
EPEC (1:200), followed by Alexa Flour 488 donkey-anti-goat secondary antibody and 
Alexa Flour 568 phalloidin. Images were acquired using a Leica SP5 LSCM, and 
cropped and contrast adjusted using ImageJ version 1.47h.
Live cell imaging
 Caco-2BBE cells were seeded on glass-bottom dishes (MatTek) and 
simultaneously transfected (Effectene) with mCherry-Utr (Burkel et al., 2007) or 
mCherry-espin (Loomis  et al., 2003) and/or PCDH24-GFP,  PCDH24ΔEC1-GFP, or 
GFP-βactin, then grown for two days. EPEC were grown and activated as described 
above. Before imaging, DMEM cell culture media was replaced with CO2-independent 
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media (Gibco). In order increase the chances of imaging productive binding events, high 
numbers of bacteria (~1x108 CFU) were added to the dishes. Cells were imaged using 
an Applied Precision DeltaVision deconvolution microscope with environmental 
chamber heated to 37° C, with z-stacks through the apical domain and time intervals of 
20 sec or 1 min. Image files were exported and processed using ImageJ version 1.47h.
Drug treatment assays
 Caco-2BBE and HeLa cells were grown on glass coverslips, the former for 14 d 
post-confluency in order to reach late differentiation. Prior to the experiment, cells were 
treated with either DMSO (1:1000) or CK-666 reconstituted in DMSO (50 µg/ml, or 
1:1000) for 2 hr. Following pretreatment, the cell culture media was replaced by serum-
free DMEM containing recovered EPEC (2x105 CFU/ml) and fresh DMSO or CK-666. 
Samples were incubated 3 hr, fixed, and processed for immunofluorescence as above 
(anti-Lipid A and phalloidin). Coverslips were imaged by LSCM, and processed using 
ImageJ version 1.47h. For quantification, z-stacks were first converted to max intensity 
projections. The EPEC channel was thresholded and converted to a binary mask and 
measured, providing a quantification of total area covered by bacteria. The binary mask 
was multiplied with the actin channel to create a 32-bit float image. In this way, only the 
area under the mask (i.e. actin in pedestals, and not the surrounding brush border or 
cell cortex) was included in intensity measurements. The resulting image was converted 
to 8-bit, and actin signal measured to quantify both pedestal area and intensity.
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CHAPTER III
ENTEROCYTE MICROVILLUS-DERIVED VESICLES DETOXIFY BACTERIAL 
PRODUCTS AND REGULATE EPITHELIAL-MICROBIAL INTERACTIONS
Originally published as:
Shifrin, D.A., Jr., McConnell, R.E., Nambiar, R., Higginbotham, J.N., Coffey, R.J., and 
Tyska, M.J. (2012). Enterocyte microvillus-derived vesicles detoxify bacterial products 
and regulate epithelial-microbial interactions. Current Biology 22, 627-631.
And
Shifrin, D.A., Jr., and Tyska, M.J. (2012). Ready...aim...fire into the lumen: a new role for 
enterocyte microvilli in gut host defense. Gut Microbes 3, 460-462.
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CHAPTER III-A
Summary
 The continuous monolayer of intestinal epithelial cells  (IECs) lining the gut lumen 
functions as  the site of nutrient absorption and as  a physical barrier to prevent the 
translocation of microbes and associated toxic compounds into the peripheral 
vasculature (Louvard et al., 1992). IECs also express host defense proteins such as 
intestinal alkaline phosphatase (IAP), which detoxify bacterial products and prevent 
intestinal inflammation (Koyama et al., 2002; Bates et al., 2007; Goldberg et al., 2008; 
Ramasamy et al., 2010). Our laboratory recently showed that IAP is  enriched on 
vesicles that are released from the tips  of IEC microvilli and accumulate in the intestinal 
lumen (McConnell and Tyska, 2007; McConnell et al., 2009). Here, we show that these 
native ‘‘lumenal vesicles’’ (LVs) (1) contain catalytically active IAP that can 
dephosphorylate lipopolysaccharide (LPS), (2) cluster on the surface of native lumenal 
bacteria, (3) prevent the adherence of enteropathogenic E. coli (EPEC) to epithelial 
monolayers, and (4) limit bacterial population growth. We also find that IECs upregulate 
LV production in response to EPEC and other Gram-negative pathogens. Together, 
these results  suggest that microvillar vesicle shedding represents a novel mechanism 
for distributing host defense machinery into the intestinal lumen and that microvillus-
derived LVs modulate epithelial-microbial interactions.
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Results and discussion
 A defining feature of the intestinal epithelial cell (IEC) apical domain is the array 
of microvilli known as the brush border, which extends into the intestinal lumen (Louvard 
et al., 1992). Within the microvillus, the apical membrane and underlying core actin 
bundle are linked by myo1a, a membrane-binding actin-based motor (Mooseker and 
Tilney, 1975; Collins  and Borysenko, 1984). Our previous studies suggest that myo1a 
applies force to the apical membrane, leading to the accumulation of membrane at 
microvillar tips and ‘‘shedding’’ of vesicles into the lumen (McConnell and Tyska, 2007; 
McConnell et al., 2009). In mice lacking myo1a, lumenal vesicles (LVs) are reduced in 
number and exhibit perturbations in morphology and composition (McConnell et al., 
2009). Proteomic studies  revealed that native LVs are enriched in intestinal alkaline 
phosphatase (IAP) (McConnell et al., 2009), a host defense factor that reduces  the 
toxicity of lipopolysaccharide (LPS) and other bacterial compounds, limits  TLR-4 
signaling, and prevents mucosal inflammation (Koyama et al., 2002; Bates et al., 2007; 
Goldberg et al., 2008; Park et al., 2009; Ramasamy et al., 2010). The absence of IAP 
also leads to alterations in gut microbiota (Malo et al., 2010). Thus, IAP plays a critical 
role in preventing mucosal inflammation and maintaining gut homeostasis.
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Figure 3-1: LVs dephosphorylate LPS and interact with native lumenal bacteria
(A) LVs release phosphate from E. coli O55:B5 LPS in a concentration-dependent manner; phosphate 
release is reduced by the IAP competitive inhibitor L-phenylalanine (L-Phe). (B) LVs (200 µg LVs/ml) and 
purified IAP (2 U/ml) differentially dephosphorylate LPS derived from various Gram-negative bacterial 
species. Data represent mean ± SEM. (C) TEM imaging reveals vesicle-like particles in close association 
with native lumenal bacteria from rat LV preparations. Scale bar represents 200 nm. (D) CM imaging 
reveals IAP enrichment (green) on membranes (red) associated with DAPI-stained bacteria (blue). Scale 
bars represent 2 µm. (E) Presort input material was analyzed for staining with both anti-IAP (LVs) and 
DAPI (bacteria) using the P4 gate. (F) P4 material  was sorted using gates for IAP (P5, low IAP 
enrichment) and dual  stained material (P6, high IAP enrichment). (G) CM images of sorted P6 material 
show native LV/microbe complexes (green = IAP, blue = DAPI). Scale bar represents 2 µm.
LV-associated IAP dephosphorylates LPS
 Given the evidence implicating IAP in gut host defense and homeostasis 
(Koyama et al., 2002; Bates et al., 2007; Goldberg et al., 2008; Park et al., 2009; Malo 
et al., 2010; Ramasamy et al., 2010), we hypothesized that IAP-enriched LVs produced 
by microvilli regulate epithelial-microbial interactions. To test this  proposal, we first 
sought to determine whether LVs could dephosphorylate the proinflammatory bacterial 
product, LPS. Dephosphorylation of LPS reduces the ability of this compound to 
activate TLR-4 on host cell membranes (Koyama et al., 2002; Park et al., 2009). Our 
laboratory previously developed methods  for isolating native microvillus-derived LVs 
from rodent small intestine (McConnell et al., 2009). Native vesicles isolated with these 
methods are able to dephosphorylate LPS from Escherichia coli serotype O55:B5 in a 
concentration-dependent manner, which was sensitive to the IAP inhibitor, L-
phenylalanine (L-phe) (Figure 3-1A) (Fishman et al., 1963). This activity was  not specific 
to E. coli O55:B5 LPS because assays with other LPS variants also gave rise to robust 
phosphate release (Figure 1B, black bars). Purified IAP added at equivalent units  of 
activity (0.1 U IAP = 10 mg LV, data not shown) demonstrated a comparable response 
(Figure 3-1B, gray bars). Kinetic analysis  of phosphate release from P. aeruginosa and 
E. coli LPS (substrates that supported the highest and lowest activities, respectively) 
revealed that P. aeruginosa LPS gives rise to higher rates  of phosphate release at lower 
substrate concentrations (i.e., exhibits a lower KM; Figure 3-2). Thus, LV associated IAP 
is  catalytically active and can dephosphorylate LPS from a variety of Gram-negative 
species.
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LVs physically interact with lumenal microbes
 Because LVs are able to chemically modify bacterial compounds (Figures 3-1A 
and 3-1B; Figure 3-2), we next sought to determine whether these vesicles could 
interact directly with lumenal microbes. To address this question, we examined 
resuspended pellets produced during native LV preparations from rat intestinal lumen 
wash using negative stain transmission electron microscopy (TEM). The resulting 
images revealed rod-shaped bacteria coated or in contact with clusters of material that 
resembled small vesicles (Figure 3-1C). We labeled the same fraction with an anti-IAP 
antibody, a membrane dye (DiD), and DAPI (to label bacteria) and imaged samples 
using laser scanning confocal microscopy (LSCM). Consistent with the presence of 
microvillus-derived LVs, we found that microbe-associated material was highly enriched 
in IAP and DiD (Figure 3-1D).
 To analyze minimally processed lumen wash material for the presence of LV/
microbe complexes, we also employed a modified form of fluorescence-activated 
vesicle sorting (FAVS) (Cao et al., 2008; McConnell et al., 2009). Raw lumen wash from 
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Figure 3-2: LVs exhibit differential affinity for LPS from different sources
Kinetic analysis of phosphate release using LPS from E. coli  O127:B8 and P. aeruginosa indicates that 
LVs likely exhibit a differential affinity for different LPS isoforms. Data represent mean ± SEM
rat small intestine was  allowed to settle at 1 x g and then passed through a 40 µm filter 
to remove large particulate matter. Samples were then labeled as in Figure 3-1D and 
applied to the flow cytometer. FAVS analysis revealed that 99% of all DAPI-labeled 
particles are associated with some level of IAP signal (P4, Figure 3-1E). Double-positive 
particles were further analyzed to select for populations with low (P5, Figure 3-1F) and 
high (P6, Figure 3- 1F) levels of IAP enrichment. Imaging of postsort ‘‘P6’’ material 
revealed numerous examples of rod-shaped bacteria surrounded by IAP-enriched 
puncta (Figure 3-1G). Thus, the LV/microbe complexes observed in conventional lumen 
wash preparations (Figures 3-1C and 3-1D) are most likely formed in the lumen and not 
as a result of centrifugation or other processing.
LVs prevent EPEC adherence to IECs
 Because LVs bind directly to lumenal bacteria, microvillar vesicle shedding could 
serve as  a host defense mechanism capable of preventing the adherence of pathogenic 
bacteria that target the IEC apical surface. To test this idea, we sought to determine 
whether LVs impacted the ability of enteropathogenic E. coli (EPEC, strain E2348/69) to 
infect human IECs (HT-29 and Caco-2BBE cells) in culture. EPEC uses a type III 
secretion system to inject factors into host cells  that lead to microvillar effacement, 
which in turn enables intimate adhesion to the apical surface, an event essential for 
EPEC pathogenesis  (Vallance and Finlay, 2000). We incubated confluent monolayers of 
HT-29 cells  with 1 x 105 colony-forming units (CFU) EPEC/ml media in the presence or 
absence of 200 µg LVs/ml media (See Chapter III, Materials  and Methods). After a 3 hr 
incubation, monolayers were stained and then imaged using CM (Figures  3-3A and 
3-3B) or SEM (Figures  3-3C and 3-3D). Consistent with a previous report (Dean et al., 
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2006), we found that IAP was enriched on the surface of bacteria bound to the cell 
monolayer, independent of the presence of actin pedestals (arrowheads, Figures 3-3A 
and 3-3B). Confocal images were further analyzed by counting (1) the number of EPEC 
organisms bound per unit area, independent of stage of attachment (Figure 3-3E), and 
(2) the number of microcolonies per unit area (Figure 3-3F) (Scaletsky et al., 1984). 
Both indices  showed that LVs significantly reduced EPEC attachment to HT-29 
monolayers (Figures 3-3E and 3-3F). Similar results were observed when experiments 
were carried out with Caco-2BBE cells (data not shown). SEM on Caco-2BBE cultures 
confirmed that EPEC actin pedestal formation was reduced in the presence of LVs 
(Figures 3-3C and 3-3D). Neither fixing LVs nor inhibiting LV-associated IAP activity with 
L-Phe impacted the ability of vesicles to limit EPEC attachment to HT-29 cells (Figures 
3-3E and 3-3F). Finally, purified IAP had little impact on the number of bacteria bound to 
the monolayer surface (Figures 3-3E and 3-3F). Thus, LVs prevent EPEC from 
intimately attaching to IECs in culture via a mechanism that does not depend on IAP 
catalytic activity.
 Bacteria and bacterial products activate proinflammatory NF-kB signaling 
(Wullaert et al., 2011). Thus, we sought to determine whether LVs were capable of 
preventing activation of NF-kB signaling in response to EPEC. A hallmark of NF-kB 
pathway activation is translocation of the transcription factor RelA into the nucleus 
(Goldberg et al., 2008). We transfected HT-29 cells  with EGFP-tagged human RelA 
(Chen et al., 2001), incubated cells  in serum free media for 3 hr, and then scored the 
fraction of transfected cells  with nuclear RelA. Under these conditions, 14% of cells 
expressing the construct demonstrated RelA in the nucleus (Figure 3-3G). In cells 
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treated with EPEC, nuclear localization of RelA is  observed in 31% of expressing cells, 
compared with 21% in EPEC-exposed cells treated simultaneously with 200 µg LVs/ml 
(Figure 3-3G). The attenuated response observed here is likely due to the fact that IECs 
limit expression of cell-surface receptors such as TLR-4, to prevent constitutive 
proinflammatory signaling (Abreu et al., 2001). Together these data indicate that LVs 
inhibit interactions between adherent pathogenic bacteria and IECs and limit the 
downstream NF-kB signaling that would otherwise be triggered by these interactions.
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Figure 3-3: LVs prevent EPEC attac hment to IECs
(A and B) CM images of HT-29 monolayers treated with EPEC 6 LVs stained for IAP (green), F-actin 
(phalloidin, red), and bacteria (DAPI, blue), show striking enrichment of IAP surrounding attached 
bacteria. Most EPEC in non-LV treated samples (A) form microcolonies and are associated with actin 
pedestals (arrows), indicating intimate attachment, whereas this rarely occurs in the presence of LVs (B). 
Arrowheads in (A) and (B) denote examples of EPEC superficially attached to the monolayer, indicated by 
the absence of pedestal formation. Scale bars represent 5 mm. (C and D) Representative SEM images of 
CACO-2BBE cells demonstrate EPEC intimately associated with the cell surface in the absence (C), but 
not the presence of LVs (D). Scale bars represent 1.67 mm. (E) The number of EPEC attached to HT-29 
cells is significantly reduced in the presence of LVs, LVs fixed in paraformaldehyde, and LVs with IAP 
activity inhibited by L-Phe, but not in the presence of purified IAP (*p < 0.05). Error bars represent SEM. 
(F) LVs also reduce the number of microcolonies formed. Error bars represent SEM. (G) Nuclear 
translocation of EGFP-RelA is increased in HT-29 cells incubated with EPEC, an effect that is partially 
ameliorated by treatment with LVs.
LVs limit bacterial population growth
 Direct association with microbes might also enable LVs to impact bacterial 
viability. To investigate this possibility, we treated liquid cultures with ~2.5 x 104 CFU 
EPEC/ml with either 0 or 50 µg LVs/ml and incubated overnight; OD600 was measured at 
10 min intervals. Although addition of LVs did not prevent initiation of log growth in 
EPEC (t = 4-8 hr), the maximum OD600 achieved in the presence of LVs was significantly 
reduced (Figure 3-4A, black lines). We carried out similar growth assays with bacterial 
isolates derived from native lumenal material using MacConkey selection (Macconkey, 
1905). As with EPEC, native isolates  entered log phase approximately 4 hr into the 
assay, but inclusion of 50 µg LVs/ml reduced the maximum OD600 (Figure 3-4A, red and 
blue lines). 16S ribosomal subunit DNA sequence analysis  showed that both 
commensals used in this assay were members of the genus Escherichia, most likely E. 
coli (data not shown). Further experimentation revealed that the impact of LVs on 
bacterial population growth is not mediated by IAP or its catalytic activity. Addition of 
purified IAP to cultures at levels that presented 1-10X the catalytic activity of 50 µg/ml of 
LVs, did not alter the start of log phase or the plateau in OD600 (Fig. 3-5A, green lines). 
To examine the possibility that other catalytic activities associated with LVs (McConnell 
et al., 2009) impact bacterial growth in these cultures, LVs were fixed with 
paraformaldehyde and then used in growth assays. Fixation of LVs did not impair their 
ability to reduce the maximum OD600 achieved by EPEC in this assay (Fig. 3-5B, light 
blue lines). Pre-treating growth media with LVs had no impact on the subsequent 
population growth of EPEC in the same media, indicating that LVs were not reducing 
the concentration of nutrients available to growing bacteria or otherwise conditioning the 
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culture environment (Fig. 3-5B, purple lines). Adding LVs to stationary phase EPEC 
cultures also led to a striking decline in OD600 over a similar 16 hr time course (Figure 
3-4B, orange lines). Comparable results were obtained with stationary EPEC cultures 
that were first replenished with fresh growth media (Figure 3-4B, dark red lines). The 
reduced OD600 values observed in bacterial population growth assays (Figs. 3-4, 3-5) 
could be the result of LVs inhibiting bacterial growth, LVs accelerating bacterial death, or 
LVs inducing aggregation of bacteria. The first possibility is unlikely given that LVs are 
able to reduce the OD600 of stationary cultures, where growth is already significantly 
diminished. To distinguish between the latter two possibilities, we sonicated bacteria 
cultured in the presence or absence of LVs, to break up any aggregates following the 16 
hr growth assays. We then plated dilutions of sonicated material on LB agar plates. The 
addition of LVs to both stationary cultures  and those starting at ~2.5x104 CFU EPEC/ml 
led to a reduction in the number of colonies counted per plate (23% and 34%, 
respectively; Fig. 3-4C). Furthermore, imaging of non-sonicated material did not reveal 
significant aggregation in the presence of LVs. Thus, LVs most likely reduce OD600 
values by accelerating bacterial death. Together, these results indicate that LVs limit the 
population density of commensal and pathogenic E. coli in a manner independent of the 
catalytic activity of IAP or other enzymes.
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Figure 3-4: LVs inhibit bacterial population growth
(A) Incubating both EPEC and native intestinal  bacterial  cultures with 50 µg LVs/ml reduces OD600 
achieved at stationary phase (t = 8–16 hr) following log growth (t = 4–8 hr). Black lines represent EPEC, 
blue and red lines represent native E. coli. (B) Stationary phase EPEC cultures incubated with LVs show 
a reduction in OD600 compared to untreated samples over the course of 16 hr, both in cultures with 
nutrient-depleted media (orange lines) or fresh media (dark red lines). Traces represent averaged 
recordings from multiple experiments (n = 3–8). (C) LVs reduce the number of viable bacteria (CFU), as 
sampled at the end of cultures started with 2.5 x 104 CFU/ml and incubated for 16 hr or stationary cultures 
incubated for 16 hr. *p < 0.05 versus untreated. Error bars represent SEM.
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Figure 3-5: Inhibition of bacterial growth is not dependent on IAP activity
(A) Inhibition of growth is not a result of IAP activity, as treatment with 5U IAP/ml, equivalent. (B) Fixing 
LVs to prevent catalytic  activity (light blue lines) does not impair the ability of LVs to inhibit EPEC 
population growth, while pre-treating growth media with LVs (purple lines) does not alter EPEC 
population growth. Traces represent averaged recordings from multiple (n = 3-8) experiments.
EPEC stimulates LV production
 All of our assays with native LVs isolated from rodent small intestine (Figures 3-1 
through 3-5) indicate that LVs likely function as a host defense platform. Because many 
host defense pathways and processes are regulated by bacterial toxins or intact 
bacteria (Garrett et al., 2010; Sharma et al., 2010), we sought to determine whether LV 
production was controlled in a similar manner. For these experiments, we developed a 
culture model of microvillar vesicle shedding using Caco-2BBE cells (Peterson and 
Mooseker, 1992; Peterson et al., 1993; Peterson and Mooseker, 1993). Caco-2BBE cells 
polarize, form a well-ordered brush border, and demonstrate robust microvillar vesicle 
shedding similar to native IECs, as indicated by the accumulation of small vesicles 
(Figure 3-6A) containing LV markers, IAP and annexin A13b (McConnell et al., 2009), in 
culture media (Figure 3-7A). When Caco-2BBE cells were exposed to ~1 x 106 CFU 
EPEC/ml for 6 hr, total cellular levels of IAP increased dramatically (Figure 3-7B), 
consistent with previous  work in zebrafish (Bates et al., 2006). EPEC exposure also 
significantly increased the amount of IAP-enriched LVs released into culture media 
(Figure 3-7C). Accumulation of IAP in the 100,000 x g pellet likely represents bona fide 
vesicle shedding, rather than microvillar fragmentation, because no actin is  observed in 
these fractions (Figure 3-7C). Additionally, Caco-2BBE cells expressing the myo1a-TH1 
domain (TH1 DN), which acts as a dominant negative inhibiting the function of 
endogenous myo1a (Tyska and Mooseker, 2004), do not release IAP-enriched vesicles 
into culture media (Figure 3-7C). We also found that vesicle shedding was stimulated, 
albeit to a lesser extent, by Shigella, another Gram-negative enteric pathogen (Figure 
3-6B) (Schroeder and Hilbi, 2008). However, vesicle shedding was not stimulated by 
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EPEC-conditioned media (Kuehn and Kesty, 2005), heat-killed EPEC, or 10 µg/ml E. 
coli O55:B5 LPS (Figure 3-7C). These findings indicate that microvillar vesicle shedding 
is  upregulated in response to EPEC exposure, and that this  response requires live, 
intact bacteria.
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Figure 3-7: EPEC stimulates LV release from IECs
(A) LVs accumulate in Caco-2BBE cell culture media over time. Media was subject to ultraspeed 
centrifugation and 100,000 x g pellets were processed for western blotting with probes for IAP and 
annexin A13b; whole cell homogenates (WCH) from each time point were processed in parallel and 
probed for actin. (B) Whole-cell  IAP expression levels increase upon exposure to EPEC. (C) EPEC 
stimulates increased LV production from CACO-2BBE cells, indicated by the presence of IAP in the LV-
containing 100,000 x g pellet fraction. EPEC-stimulated LV production is attenuated by expression of a 
myo1a dominant-negative construct (TH1 DN). Shedding requires intact, live bacteria, because EPEC-
conditioned media, heat-killed EPEC, and purified LPS fail to stimulate LV production.
Figure 3-6. Live bacteria stimulate LV release from IECs
(A) Negative stain TEM of the 100,000 x g pellet reveals vesicle-like particles that exhibit the 
characteristic  size (50-100 nm diam.) of native LVs. Bar, 100 nm. (B) Like EPEC, both WT Shigella and a 
strain lacking the virulence plasmid stimulate increased shedding of LVs from CACO-2BBE cells, seen by 
the presence of IAP in the LV containing 100,000 x g pellet fraction.
Conclusions
 Previous work investigating the physiological function of IAP has focused on the 
activity of this enzyme as  a soluble or cell-associated host defense factor in the gut 
lumen (Koyama et al., 2002; Bates  et al., 2007; Goldberg et al., 2008; Chen et al., 
2010a; Ramasamy et al., 2010). The findings reported here suggest that microvillar 
vesicle shedding is  a mechanism for distributing IAP activity into the mucous layer or gut 
lumen. Deploying IAP in this manner would enable chemical modification of bacterial 
toxins (i.e., dephosphorylation of LPS; Figures 3-1A and 3-1B; Figure 3-2) at sites distal 
to the apical surface of IECs. However, LVs also limit the attachment of pathogenic 
bacteria to IECs and inhibit bacterial population growth (Figures 3-3, 3-4 and 3-5). 
Moreover, IAP expression and LV production are upregulated by pathogenic Gram-
negative bacteria (Figure 3-6 and 3-7). Based on these data and the fact that trillions of 
microvilli extend from the surface of IECs, we propose that microvillar vesicle shedding 
represents a powerful mechanism for limiting the potentially harmful impact of microbes 
and associated proinflammatory compounds that accumulate in the intestinal lumen. 
Future studies  must focus on defining mechanisms that regulate LV production in 
response to microbial signals, mechanisms responsible for the impact of LVs on 
bacterial viability, and the role of LV production in animal models of gut disease.
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CHAPTER III-B
 The intestinal lumen is home to an astoundingly large population of microbes, 
many of which contribute to normal physiological function (Backhed et al., 2005). To 
prevent these and other, potentially pathogenic bacteria from stimulating inflammation in 
host tissues, the lumen is  enclosed by a tightly regulated barrier formed from a 
monolayer of intestinal epithelial cells, also referred to as ‘enterocytes’. Enterocytes 
carry out both absorption and barrier functions in part via an apical array of actin-based 
microvilli collectively known as the brush border. While a significant percentage of brush 
border proteins  are involved in nutrient processing, nutrient absorption, and the 
maintenance of microvillar structure, others play roles in host defense (McConnell et al., 
2011). Among the most abundant of these is IAP, a GPI-anchored enzyme responsible 
for cleaving phosphate groups from bacterial compounds, including the potent pro-
inflammatory toxin, LPS (Poelstra et al., 1997). Dephosphorylation of these molecules 
renders them less effective at activating host cell TLRs (Rietschel et al., 1994; Park et 
al., 2009). Studies in the last decade have demonstrated that IAP expression is 
stimulated by intestinal microbes (Bates  et al., 2006) and that the resulting higher levels 
of IAP protect against microbe-induced inflammation (Bates  et al., 2007; Ramasamy et 
al., 2010). Moreover, treatment with exogenous IAP can limit inflammation upon 
toxigenic insult in vivo (Beumer et al., 2003; van Veen et al., 2005). Thus, IAP is a 
critical component of innate intestinal immunity.
 Work in our laboratory previously demonstrated that specialized membrane 
vesicles (lumenal vesicles, LVs) are released from the distal tips of enterocyte microvilli 
(McConnell and Tyska, 2007; McConnell et al., 2009). Biochemical analysis of LVs 
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revealed that IAP (McConnell et al., 2009) is  concentrated on the lumenal surface of 
these membranes (McConnell et al., 2009); such topology would allow the enzyme 
access to lumenal toxins and further suggested a physiological function for LVs in host 
defense. Our more recent studies showed that LVs are in fact able to interact with and 
limit the pro-inflammatory potential of both bacteria and bacterial products (Shifrin et al., 
2012). Based on these recently published findings, we propose a multi-faceted model 
for LV function in gut host defense (Figure 3-8). First, IAP-enriched LVs are released 
into the intestinal lumen where they likely function in detoxifying pro-inflammatory 
bacterial toxins such as LPS, which accumulate during the bacterial life cycle. Second, 
LVs also bind directly to bacteria, which may serve to aggregate microbes and facilitate 
their clearance from the intestine, or prevent the adherence of virulent species  to the 
enterocyte apical surface, thereby reducing the probability of infection. Finally, because 
LVs also exhibit bactericidal properties, they might regulate the gut microbiota by 
preventing harmful overgrowth.
 One important question is whether LVs are produced in large enough numbers to 
exert a significant effect on gut homeostasis. From a purely theoretical standpoint, the 
vast numbers  of microvilli that extend into the lumen suggest an enormous potential for 
LV production to impact mucosal physiology. For example, the rodent small bowel 
contains approximately ~1012 microvilli and an estimated ~108 microbes. Thus, LV-
producing organelles outnumber bacterial organisms by at least four orders of 
magnitude. It is also worth noting that our recently described studies of LV function 
(Shifrin et al., 2012) were carried out using at most a concentration of 200 µg/ml (total 
LV protein). This  level is equivalent to the physiological concentration of LVs captured 
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from lumen wash preparations and was sufficient to produce robust effects in assays of 
bacterial attachment and growth (Shifrin et al., 2012). Finally, although LVs can be 
collected from lumen wash samples (McConnell et al., 2009; Shifrin et al., 2012), our 
preliminary ultrastructural and immunofluorescence analyses suggest that a large 
fraction of LVs are trapped in the mucus layer that protects enterocytes. Such trapping 
is  likely to further increase the effective lifetime and thus, the steady-state level of LVs 
present in the gut lumen.
51
Figure 3-8: A multi-faceted role for LVs in gut homeostasis
The enterocyte brush border produces IAP-enriched LVs, which are found both in the gut lumen and 
trapped in the mucus layer. As a result, LVs are well positioned to: (1) detoxify soluble bacterial LPS using 
IAP catalytic  activity, (2) bind lumenal  bacteria to facilitate clearance and to prevent potential pathogens 
from adhering to the epithelial  surface, and (3) help regulate microbial  populations by exerting a 
bactericidal effect.
 If LV production does play a role in limiting host-microbe interactions in the gut, 
defective vesicle production would be expected to produce significant perturbations in 
gut homeostasis such as inflammation and a dysregulated microbiota. Mice that lack the 
shedding motor, myosin-1a (myo1a), produce fewer LVs and those that are formed lack 
the characteristic enrichment of IAP (McConnell et al., 2009). These animal do shows 
signs of chronic low level inflammation, including a greater number of goblet cells per 
villus, increases in the cytokines IL-1α and IL-6, and shifts in the small intestine 
microbiota at the family level (unpublished observations). Despite these differences, 
however, myo1a KO mice show no overt phenotype (Tyska et al., 2005), most likely as 
a result of compensatory mechanisms such as the expression of the closely related 
motor, myosin-1d (Benesh et al., 2010). In this light, additional animal models that 
demonstrate more complete loss of LV production must be developed before we can 
fully appreciate the full range of LV functions in vivo.
 Several important questions regarding the mechanism of LV production remain 
unanswered. How is the GPI-anchored protein IAP targeted to microvillar tips, and why 
is  this  enrichment lost in the myo1a KO brush border (McConnell et al., 2009)? Our 
unpublished observations show that microvillar tips are enriched in cholesterol, which 
provides the backbone for lipid raft formation (Karnovsky et al., 1982). Moreover, 
microvilli and LVs both contain raft-associated annexin 2 as  well as  A13b (Massey-
Harroche et al., 1998; McConnell et al., 2011), proteins that have been implicated in 
membrane organization and deformation (Gerke et al., 2005). Thus, one possibility is 
that a distinct lipid raft-like environment, which favors high membrane curvature, exists 
at the distal tips  of microvilli and helps to attract machinery that might drive LV budding. 
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High levels  of cholesterol would also favor the enrichment of IAP, which is  anchored to 
the external leaflet via a GPI-anchor (Paulick and Bertozzi, 2008). An alternative 
possibility is  that ESCRT complex components mediate vesicle formation. ESCRT 
complexes are involved in membrane abscission, and as such play a role in viral 
budding, cytokinesis, and multi-vesicular body formation (Henne et al., 2011). Given that 
these events are topologically similar to LV release from microvillar tips, ESCRT 
proteins are also good candidates for driving this  process. Beyond these speculative 
points, a detailed investigation of protein and lipid composition at microvillar tips has yet 
to be described, but will be needed before we fully understand the molecular 
mechanism of this novel facet of gut host defense.
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CHAPTER IV
THE ABSENCE OF MYO1A LEADS TO INTESTINAL PERTURBATION
Summary
 Data from biochemical, cell culture, and bacterial culture assays demonstrate 
that LVs are enzymatically active organelles that also have a possible physical role in 
inhibiting bacterial attachment to host cells (Shifrin et al., 2012). The intestinal lumen 
contains vast numbers of bacteria, many of which are Gram-negative and carry toxins 
that are IAP substrates (Chen et al., 2010b). Our model of LV function suggests that 
these organelles  are released by enterocyte microvilli, following which some are 
released into the lumen and others likely become incorporated into the mucus layer 
lining enterocytes (Fig. 5-1). LVs then interact with lumenal contents, binding to bacteria 
and inhibiting pathogenic attachment to the epithelia, while LV-bound IAP 
dephosphorylates LPS and other toxins released during the bacterial life cycle. In the 
absence of vesicle shedding, therefore, we would hypothesize that pro-inflammatory 
signaling increases, leading to loss of intestinal homeostasis.
Results
IAP enrichment at microvillar tips is reduced in the absence of myo1a
 Previous work from our lab established that the absence of myo1a gives rise to 
perturbations in LV production; mice lacking myo1a produce fewer LVs, which contain 
lower levels of IAP and are significantly larger than LVs produced by WT animals 
(McConnell et al., 2009). Consistent with this, immunofluorescence staining revealed 
that IAP distribution is altered in the brush borders of myo1a KO small intestine. IAP 
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signal is evident along the length of KO microvilli, with a heavy concentration observed 
in a band just above the terminal web at the base of microvilli (Fig. 4-1A). 
Concomitantly, few tip-enriched IAP puncta, which represent LV precursors, are 
observed in KO tissue (Fig. 4-1B). This distribution is inverted relative to WT animals; 
some microvillar localization is seen, with a slight accumulation at the base of microvilli 
and a gradient along the length of the actin (Fig. 4-1A). However, the majority of IAP 
signal in WT tissue is past the distal tips of the microvilli in LV precursors (Fig. 4-1B). It 
is  possible that the absence of myo1a perturbs microvillar lipid composition, altering the 
distribution of cholesterol enriched lipid rafts  and thereby preventing normal segregation 
of raft-associated proteins. A population of myo1a is  important for retaining SI in the 
microvillus, and SI is depleted in LVs relative to microvillar membrane (Tyska and 
Mooseker, 2004; McConnell et al., 2009). Thus, myo1a may be important for partitioning 
microvillar membrane by linking a sub-population of membrane lipids to the underlying 
core actin bundle. IAP-containing rafts, unconstrained by a cross-linker and with a 
possible preference for high-curvature, could diffuse out to the distal tips and for LV 
precursors. A specific mechanism for IAP enrichment and LV scission from microvillar 
tips should be the focus of future studies.
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Defects in LV production are linked to alterations in the lumenal microbiota in 
vivo
 Given that microvillus-derived LVs interact directly with native lumenal bacteria, 
prevent adherence of pathogenic bacteria to epithelial cells, and impact the growth of 
the E. coli strains in vitro, we examined the possibility that LVs might function in 
regulating the growth and diversity of bacterial species  that reside in the gut lumen.  To 
determine if defective LV production observed in myo1a KO mice is associated with 
perturbations in the gut microbiota, we isolated DNA from WT and myo1a KO distal gut 
contents and amplified bacterial DNA encoding the 16S ribosomal subunit using the 
conserved 8F/1492R primer set (Eden et al., 1991; Schmidt and Relman, 1994). We 
then sequenced amplified PCR products with the conserved primer 907R (Wen et al., 
2008), and used the Ribosomal Database Project (Wang et al., 2007) to identify bacteria 
from which the DNA was derived, discarding sequences with < 80% confidence at the 
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Figure 4-1: IAP distribution is altered in the absence of myo1a
(A) LSCM images of frozen sections from WT and myo1a-KO mouse small intestine show that 
characteristic  WT IAP enrichment at the distal tips of microvilli is reduced in the absence of myo1a.  IAP 
signal in KO microvilli  is observed less frequently at microvillar tips, and instead is seen more evenly 
distributed along the microvillar axis. Tissue processing and staining is described in (McConnell and 
Tyska, 2007). (B) Quantification of IAP puncta at the tips of microvilli in WT and myo1a KO small 
intestine. n = 4 WT and 3 KO small intestines.
genus level (n of sequences ≥ 80% confidence = 458 for WT and 433 for myo1a KO). 
Although we did not observe significant changes at the phylum level when comparing 
WT and myo1a KO samples, two striking shifts occur within the phylum Bacteroidetes 
(blue segments, Fig. 4-2), one of the two dominant phyla that comprise the distal gut 
microbiota (Ley et al., 2008). As proportions of total sequences, family Bacteroidaceae 
is  increased in KO animals by 43.0% and family Porphyromonadaceae is reduced by 
21.3% (Fig. 4-2 and Table 4-1). Other notable changes include a 10.7% increase in the 
abundance of Prevotellaceae and 13.9% increase in Rikenellaceae.
 Although the percent change varies from previously published studies, the 
bacterial families affected in our analysis are consistent with other work demonstrating 
shifts in the microbiota following antibiotic treatment (Wlodarska et al., 2011), infection 
by the murine pathogen Citrobacter rodentium (Lupp et al., 2007), and genetic 
manipulation of the TLR-4/NF-κB pathway in a mouse model of diabetes (Wen et al., 
2008). Little is known about the function of Porphyromonadaceae in the intestine, or the 
consequences of alterations in relative abundance. Prevotellaceae, however, are 
commensals observed to be opportunistic pathogens in humans (2009). Similarly, the 
genera Bacteroides of the family Bacteroidaceae, contains  both critical commensal 
species, as  well as opportunistic pathogens such as  B. fragilis (Wexler, 2007). These 
results show that the absence of myo1a and associated defects in LV production are 
linked to alterations in the gut microbiota and suggest a role for microvillar vesicle 
shedding in maintaining gut homeostasis.
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Figure 4-2: Deficiencies in LV shedding are associated with an altered gut microbiome
Analysis of bacterial 16s rDNA sequences isolated from the WT and myo1a KO mice reveals shifts in the 
distal gut microbiota, especially in families of the Gram-negative phylum Bacteroidetes (blue segments), 
which is the predominant gut phylum and includes species of commensals and opportunistic pathogens. 
Notable shifts include increased numbers of the family Bacteroidaceae and decreases in 
Porphyromonadaceae, which consist primarily of benign commensal species but also include 
opportunistic pathogens.
Phylum Family WT (n = 458) KO n = (433)
Bacteroidetes Bacteroidaceae* 15.50% (71) 22.17% (96)
Porphyromonadaceae* 46.94% (215) 36.95% (160)
Prevotellaceae 4.59% (21) 5.08% (22)
Rikenellaceae 8.52% (39) 9.70% (42)
Deferribacteres Deferribacteraceae 0.66% (3) 0.23% (1)
Firmicutes Lachnospiraceae 16.16% (74) 18.48% (80)
Lactobacillaceae 0.00% (0) 0.23% (1)
Ruminococcaceae 2.84% (13) 4.16% (18)
Proteobacteria Desulfovibrionaceae 0.22% (1) 0.00% (0)
Helicobacteraceae 1.97% (9) 1.15% (5)
Tenericutes Anaeroplasmataceae 0.87% (4) 0.92% (4)
TM7 unknown 1.75% (8) 0.92% (4)
TABLE 4-1. Changes in the distal gut microbiome of LV-deficient myo1a KO mice
*Analysis of over 400 bacterial 16S sequences isolated from the distal intestines of seven WT and seven 
myo1a KO FVB mice (identity at ≥ 80% confidence) reveals striking increases in the Bacteroidaceae 
population and concomitant decreases in the Porphyromonadaceae, both of the Gram-negative phylum 
Bacteroidetes.
Myo1a KO mice exhibit signs of chronic, low-level intestinal inflammation
 Alterations in the gut microbiota are frequently associated with an inflammatory 
state; shifts in bacterial populations can both cause intestinal perturbation and be the 
result thereof (Peterson et al., 2008; Packey and Sartor, 2009). In light of our data 
showing family level shifts  in the microbiota of myo1a KO mice, we next sought to 
determine if these animals exhibit an inflammatory phenotype. Original characterization 
of the myo1a KO mouse found significant ultrastructural changes  relative to WT (Tyska 
et al., 2005). These include variable microvillar length and loss of tight hexagonal 
packing, substantial membrane herniations at the tips of microvilli, changes to villar 
morphology, and a loss or reduction in the localization of several brush border proteins 
(Tyska et al., 2005). However, these animals were of comparable size to WT and had 
normal behavioral habits. Clearly, although the absence of the microvillar motor myo1a 
caused alterations to the KO enterocyte, the defects were not strong enough to 
significantly perturb overall animal health. For this analysis, then, we focused 
specifically on inflammatory markers, which had not been investigated in the original 
work.
 Goblet cells secrete mucins, which form a two-layer coating across the intestinal 
epithelia to prevent bacterial contact with the host cells and subsequent infection 
(McGuckin et al., 2011). We stained small intestine Swiss rolls with Periodic acid-Schiff 
(PAS)/Alcian blue to label the glycoproteins, glycolipids, and mucopolysaccharides 
produced by goblet cells. Quantification revealed a ~25% increase in the number of 
goblet cells per villus in the small intestine . Along the length of the tissue, the number of 
goblet cells per villus  decreased slightly from proximal to distal in the WT intestine, from 
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~8.5 to ~7.25 (Fig. 4-3A, B). This decrease is likely due in part to the steady decline in 
villus  length that occurs from the duodenum to the ileum. Interestingly, no decrease was 
observed along the myo1a KO intestine, with the average number of goblet cells  per 
villus  remaining steady at 10 (data not shown). The microbiota is  important for cell fate 
decisions in intestinal epithelia; germ-free mice have lower numbers of goblet cells than 
their normally colonized counterparts (Kandori et al., 1996; Fukushima et al., 1999). 
Goblet cell differentiation is defective in mouse models of ulcerative colitis, leading to a 
defficient mucus layer due to reduction in mucus and defensin secretion (Gersemann et 
al., 2011; Gersemann et al., 2012). Infection and subsequent inflammation increases 
significantly in mice lacking MUC1, a mucin produced by goblet cells (McGuckin et al., 
2011). Furthermore, mutations in this same gene have been implicated in inflammatory 
bowel disease in humans (McGuckin et al., 2011). Goblet cell metaplasia is also 
observed in mouse models of airway inflammation, a response which can be attenuated 
by the introduction of non-pathogenic E. coli (Pang et al., 2013). It may be, then, that 
shifts in the microbiota cause perturbations to intestinal homeostasis, inducing a slight 
increase in goblet cell differentiation to help protect the epithelium.
 We also observed regions  of excessive eosinophil infiltration in myo1a KO colon 
tissue (Fig. 4-3C). As with the increase in goblet cell numbers, eosinophils are likely part 
of a low-level inflammatory response. Although specific roles for these cells in the 
intestine remain unclear, eosinophils  have been implicated in antimicrobial processes in 
response to the presence of Gram-negative lipopolysaccharide, as well as promoting 
increased mucus production (Woodruff et al., 2011).
60
61
Figure 4-3: Myo1a KO intestines show histological signs of inflammation
(A) PAS/Alcian blue staining of paraffin-embedded small intestine to label mucus-producing goblet cells 
shows that a greater number of these cells occur in myo1a KO villi  when compared with WT. Increased 
numbers of goblet cells is associated with inflammation. (B) Quantification of tissue shown in ‘A.’ Each 
data point represents one villus. (C) Hematoxylin & Eosin staining of mouse colon shows regions of 
eosinophil infiltration into the lamina propria layer of myo1a KO tissue.
 A hallmark and key regulator of inflammatory signaling is the increased 
expression of various cytokines. Interleukin-1α (IL-1α) and IL-6 are two of these 
proinflammatory cytokines, responsible for activating an array of immune responses 
(Bankers-Fulbright et al., 1996; Jin et al., 2010). We flushed WT and myo1a KO small 
intestines, removed and homogenized the mucosal layer, and subjected the resulting 
material to ELISA analysis for IL-1α and IL-6. Both cytokines were slightly elevated in 
KO tissue, with IL-1α levels increased by ~25% and IL-6 expression up by ~70% (Fig.
4-4).
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Figure 4-4: Increased cytokine production in myo1a KO intestinal tissue
ELISA of homogenized small  intestinal mucosa for two proinflammatory cytokines, (A) IL-1α and (B) IL-6, 
show slight, but notable increases in the absence of myo1a. These molecules are key regulators of 
inflammatory signaling, elevation indicates perturbation of intestinal homeostasis.
Discussion
 Together, these histological and biochemical findings suggest chronic, though 
low-level inflammation in the myo1a KO intestine. Despite the observed changes in the 
microbial population markers of inflammation, these animals are healthy under typical 
laboratory housing conditions. Clearly, the loss  of normal LV shedding is enough to 
perturb intestinal physiology, but not enough to cause a significant deficit in host 
defense. This is likely due to multiple factors, centered around the idea that because the 
mamallian intestine is critical for survival in the context of both nutrient absorption and 
host defense, intestinal architechure is highly redundant to minimize significant 
problems. Importantly, IAP still reaches the lumen in the myo1a KO intestine. LVs are no 
longer shed in a regulated manner from myo1a KO microvilli; however, membrane is still 
released as a result of microvillar herniations  (Tyska et al., 2005; McConnell and Tyska, 
2007; McConnell et al., 2009). Similarly, IAP is still present in these membrane fractions, 
though not specifically enriched (McConnell et al., 2009). A soluble form of IAP is found 
in serum after feeding, likely released from membrane by the action of PI-PLC or PI-
PLD and secreted from the basolateral compartment (Harris, 1990); it is possible that 
there may also be a limited amount of IAP released from the apical domain.
 The constant pressure of inflammatory signals could also lead to a 
downregulation of TLRs in myo1a KO epithelia. TLR-4 levels are relatively low in 
enterocytes as a means to prevent excessive response to the permanent presence of 
bacterial signaling molecules in the intestinal lumen (Abreu et al., 2001). Similarly, IAP 
deficient mice are less responsive to treatment with LPS due to downregulation of its 
receptor, TLR-4 (Chen et al., 2010a). Thus, a reduction in IAP-enriched LVs in the 
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intestinal lumen would leave higher concentrations  of phosphorylated (i.e. toxic) 
bacterial molecules, forcing the host epithelia to downregulate receptors  in order to limit 
an inflammatory signaling cascade.
 A final possible component to the limited phenotype observed in myo1a KO 
animals is the presence of a compensatory motor protein, myosin-1d (myo1d). Work 
from our lab has shown that in the absence of myo1a, myo1d localization in the 
microvillus increases by > 2-fold over WT and distributes along the length of microvilli. 
This  shift in localization from characteristic bands at the base and tip of microvilli may 
allow myo1d to partially rescue membrane tension by serving as a compensatory cross-
linker with microvillar actin (Benesh et al., 2010).
 These studies  further support the growing body of literature demonstrating the 
importance of IAP in maintenance of intestinal homeostasis, and strongly implicate LVs 
as mediators of IAP delivery to the intestinal lumen. Without the ability to completely 
ablate LV/membrane release, it will be difficult to fully elucidate the extent to which IAP-
enriched LVs function in host defense. Future studies should also focus on the response 
of myo1a KO mice to pathogenic challenge. It is possible that the limited inflammatory 
phenotype observed during normal conditions could be exacerbated in the presence of 
an enteric pathogen such as Citrobacter rodentium, the murine equivalent of EPEC. 
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CHAPTER V
EXTRACELLULAR VESICLES: COMMUNICATION, COERCION, AND 
CONDITIONING
Originally published as:
Shifrin, D.A., Jr., Beckler, M.D., Coffey, R.J., and Tyska, M.J. (2013). Extracellular 
vesicles: communication, coercion, and conditioning. Molecular Biology of the Cell 24, 
1253-1259.
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Introduction
 Cells  play an active role in shaping their local environment by releasing factors 
that impact neighboring cells or manipulate the biochemical properties of the 
extracellular milieu. Although soluble protein ligands have received the most 
experimental attention in this regard, a rapidly growing field of investigation suggests 
that these events are also mediated by small extracellular vesicles (ECVs). Indeed, 
ECVs are now known to affect events  ranging from immune signaling to angiogenesis  to 
detoxification of bacterial products (Thery et al., 2009; Mause and Weber, 2010; Shifrin 
et al., 2012). In these cases and many others, ECVs facilitate the distribution of specific 
cargoes that mediate communication with or coercion of other cells, or the conditioning 
of the extracellular environment.  
ECVs range in size from ~50-500 nm and are typically enriched in specific 
proteins and lipids, which differentiates their composition from the plasma membrane 
(Mause and Weber, 2010). One challenge for investigators new to this  field is the 
variable and confusing nomenclature that exists in the ECV literature; this  is primarily a 
result of the many cellular sources, isolation procedures, and apparently distinct 
mechanisms of formation. For the purposes of this  discussion, we group ECVs into two 
broad categories  that are distinguished by their mechanism of formation: exosomes and 
ectosomes. Exosomes  (40-100 nm) are likely produced through an exocytic pathway via 
the formation of multi-vesicular bodies (MVBs) and their subsequent fusion with the 
plasma membrane (Mathivanan et al., 2010). In contrast, ectosomes range from 
100-500 nm in diameter and are released through outward budding of the plasma 
membrane. Other names for ectosomes one might encounter in the literature are 
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‘microvesicles’, ‘membrane particles’, ‘microparticles,’ or ‘nanoparticles’ (Bastida et al., 
1984; Thery et al., 2001; Cocucci et al., 2009; Mathivanan et al., 2010; van der Pol et 
al., 2012). Both exosomes and ectosomes are formed such that the original plasma 
membrane topology is  maintained, i.e. vesicles are released into the extracellular space 
with membranes ‘right-side out‘ (van der Pol et al., 2012). Exosomes and ectosomes 
are produced by a vast array of cell types in a variety of physiological contexts, 
suggesting that they may contribute to many essential aspects of cell and tissue 
function, some of which will be discussed in more detail below.
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Figure 5-1: Extracellular vesicle 
biogenesis and function.
Extracellular vesicles are formed via two 
known biogenesis pathways: exosomes 
v i a a n e n d o m e m b r a n e M V B 
intermediate, and ectosomes via direct 
budding from the plasma membrane. 
Once released into the extracellular 
environment, ECVs perform one of four 
general functions: 1) regulation of gene 
expression, 2) activation of cell 
signaling, 3) distribution of catalytic 
activity, and 4) cellular trash removal.
Mechanisms of ECV formation
Exosome biogenesis
 Although the molecular details  underlying exosome production remained unclear 
for many years, recent models have converged on a late-endosomal, MVB-dependent 
pathway  (de Gassart et al., 2004; Hurley and Odorizzi, 2012). How specific cargoes 
destined for exosomes sort into these membranes and how differentiated vesicles  bud 
into the lumen of the MVB is still a matter of debate. An initial lipid-centric model 
suggested that ceramide enrichment in endosomal membranes was a major driving 
force (Trajkovic et al., 2008). Because of the small size of its head group, ceramide may 
directly influence the shape of the membrane to promote bending and downstream 
budding of vesicles. This model also invokes ceramide in the formation of raft-like 
domains that presumably function to sort specific cargo molecules  into exosomal 
membranes, although this point has not been tested directly. A second model that has 
gained support more recently suggests that exosome formation follows a mechanism 
that parallels the endolysomal degradation pathway, which relies on the function of 
ESCRT (endosomal sorting complex required for transport) complex machinery to 
generate MVBs (van Niel et al., 2006). Indeed, RNAi silencing of key ESCRT 
components tumor susceptibility gene 101 (TSG101, ESCRT-I), vacuolar protein sorting 
(VPS)22 (ESCRT-II), charged multivesicular body protein (CHMP)2A, CHMP4A/B/C 
(ESCRT-III), VPS4A/B, or ALIX (an ESCRT-III interacting protein) significantly reduces 
exosome production in MCF-7 cells (Baietti et al., 2012). Other studies reported 
decreased exosome secretion from dendritic cells after silencing of the ESCRT-0 
protein hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) (Tamai et al., 
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2010). Cargoes destined for endolysomal degradation are selectively recruited to the 
limiting membrane of the MVB through a process  that involves their ubiquitylation and 
subsequent ubiquitin-dependent interactions with ESCRT-0, I, and II (Raiborg and 
Stenmark, 2009).  However, ALIX can bind directly to exosomal cargo molecules, which 
might represent a ubiquitin-independent recruitment mechanism and also provide a 
point of distinction between sorting into exosomes versus endolysosomes (Baietti et al., 
2012; Hurley and Odorizzi, 2012). Although the extent of functional overlap between the 
ceramide-dependent and ESCRT-dependent pathways outlined here is  currently 
unclear, the mechanistic details will likely become the focus of future studies.
Following MVB formation, a subset of these organelles fuse with the plasma 
membrane and release their constituent exosomes (Thery et al., 2002). Although little is 
known about the direct regulation of MVB fusion with the plasma membrane, it appears 
that several Rab GTPases, including Rab5, Rab27, and Rab35 are involved in exosome 
secretion (Vanlandingham and Ceresa, 2009; Hsu et al., 2010; Ostrowski et al., 2010; 
Baietti et al., 2012). Further investigation will be needed to clarify the role of various Rab 
proteins in MVB fusion with the plasma membrane and exosome release.
Ectosome biogenesis
 Although comparatively little is known about the details of ectosome formation, 
current evidence suggests  that ectosomes are produced not from an endomembrane 
system as for exosomes, but by direct budding from the plasma membrane (Thery et 
al., 2009). Despite this  seemingly significant mechanistic distinction, proposed models 
of ectosome formation include elements  that are common to the production of 
exosomes. For example, the topology of outward budding from the plasma membrane is 
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equivalent to budding into the MVB lumen. Thus, one might expect the ESCRT system 
to be involved in ectosome formation. Indeed, recent studies revealed that arrestin-
domain containing-1 (ARRDC1) interacts with the ESCRT component TSG101, during 
ectosome shedding directly from the plasma membrane (Nabhan et al., 2012). Another 
parallel with exosome production is related to the significance of specific lipids in vesicle 
budding from the plasma membrane. ECVs of both types are enriched in cholesterol, 
ceramide, and other lipids implicated in raft formation. In glial cells, for example, 
production of ceramide is thought to promote membrane curvature during ectosome 
formation (Bianco et al., 2009).
An alternative pathway for ectosome formation might involve actin-based motors. 
In the context of the enterocyte brush border, the membrane-binding motor, myo1a, 
distributes along the length of the microvillus  where it exerts plus-end (tip-ward) directed 
force on the apical membrane (McConnell and Tyska, 2007). This activity leads to the 
accumulation of membrane at microvillar tips, which in turn drives the formation and 
release of ectosomes into the gut lumen (80-100 nm in diameter). Mice lacking myo1a 
produce fewer ectosomes and those that are released lack characteristic enrichment of 
cargo molecules, such as  the host defense factor intestinal alkaline phosphatase 
(McConnell et al., 2009). Although the involvement of myo1a in this system is  likely an 
adaptation linked to the unique morphology of the microvillus, these studies  suggest 
that manipulation of plasma membrane mechanics is of central importance to the 
mechanism of ectosome formation.
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TABLE 5-1: Physiological roles of ECVs
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Physiological roles of ECVs 
 ECVs are released from a variety of ‘donor’ cell types and contribute to an array 
of physiological processes.  In the following section, our discussion of ECV function is 
organized according to physiological context; key examples and relevant references are 
highlighted in Table 5-1.
Development
 While relatively little is  known about ECVs during vertebrate development, 
several reports  provide clues as to how these vesicles might contribute to normal 
morphogenesis. ECVs are detected in the peripheral circulation of pregnant women and 
ECV cargo vary based on the phase of gestation (Abrahams et al., 2004; Frangsmyr et 
al., 2005; Atay et al., 2011; Clifton et al., 2012). Although it is unknown how ECVs act 
during gestation, studies have shown that proteins with established functions in 
development are found in ECVs. For example, β-catenin, Wnt, and the Wnt cargo 
receptor Evi are components of exosomes purified from cultured human (HEK293, 
Caco-2) and Drosophila (S2,Kc167) cells  (Chairoungdua et al., 2010; Gross et al., 
2012). The function of β-catenin- and Wnt-containing exosomes is not clear at present, 
but given the central role these proteins play in tissue and organ development (Petersen 
and Reddien, 2009), it is  tempting to speculate that their function may be facilitated by 
distribution in ECVs. Additionally, sonic hedgehog (SHH) is  contained in ECVs from 
activating T lymphocytes, and these vesicles appear to function in promoting 
neovascularization (Soleti and Martinez, 2012). SHH has critical functions during 
embryogenesis, including patterning of the nervous system (Fuccillo et al., 2006) and 
development of the GI system and other endoderm-derived organs (van den Brink, 
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2007). Thus, with high concentrations  of the morphogen, it seems likely that SHH-
containing ECVs could exert similar effects on developing organs  and tissues. 
Combined, these studies are suggestive of developmental roles for ECVs, but future 
studies are warranted to clarify functional roles and molecular mechanisms.
Immunity
 ECVs are shed from immune cells, with upregulated production occurring upon 
stimulation by inflammatory signaling (van der Pol et al., 2012; Cicero, 2013). 
Conversely, infected cells can also release ECVs, which target immune cells and 
activate innate responses (Dreux et al., 2012). For example, hepatitis  C-infected cells 
release viral RNA packaged inside exosomes (genetic material is a common ECV 
cargo), which are then taken up by plasmacytoid dendritic cells (Dreux et al., 2012). 
Moreover, ectosomes shed from intestinal epithelial cells are highly enriched in 
intestinal alkaline phosphatase, and serve to both detoxify soluble bacterial LPS and 
inhibit bacterial colonization of the intestinal epithelial surface (Shifrin et al., 2012). 
Lumenal ECVs are shed constitutively as they can be isolated from the small intestine 
of uninfected rodents and sterile cell culture models. However, ectosome production 
increases dramatically in the presence of bacterial pathogens (Shifrin et al., 2012). 
Similarly, ECV shedding from macrophages and microglial cells is dependent upon 
activation of the ATP receptor and ligand-gated ion channel P2X7, which can be induced 
by exogenous ATP (e.g. as a result of cellular injury) or through normal ATP release into 
the extracellular environment of astrocyte-microglia co-cultures ((Bianco et al., 2005; 
Thomas and Salter, 2010). P2X7 can also be activated during sterile inflammation 
(Thomas and Salter, 2010). ATP released from astrocytes  in culture is sufficient to 
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stimulate ECV release from microglia (Bianco et al., 2005); these vesicles carry pro-
inflammatory cytokines, including IL1-β, and are capable of activating other 
macrophages and perhaps dendritic cells  (Thomas and Salter, 2010). Activation of 
macrophages by ECVs suggests the initiation of a large-scale inflammatory response. 
However, it is possible that in some instances the targeted, local activation of ECV 
shedding through TLR-4 signaling or other inflammatory mechanisms could actually 
prevent such a system-wide process. By releasing lumenal ECVs to combat bacterial 
attachment, for example, enterocytes could mitigate the spread of the infection, thereby 
abrogating the need for mounting a systemic anti-inflammatory response (Shifrin et al., 
2012). In the case of virally infected cells, host cells use ECVs to communicate with 
neighboring uninfected cells, which serves to initiate an immune response (Dreux et al., 
2012). This allows an appropriate local scale response without hyper-activating the 
immune system or further spreading the pathogen.
Bone formation
 Matrix ECVs found in the epiphysis of long bones bear a strong resemblance to 
ECVs shed from enterocyte microvilli. Matrix ECVs are ectosomes, released during the 
calcification process  and are highly enriched in tissue non-specific alkaline phosphatase 
(Golub, 2009, 2011). This  enzyme decreases the concentration of inorganic 
pyrophosphate, increases that of inorganic phosphate, and as a result promotes 
hydroxyapatite formation and bone mineralization (Golub, 2011). Although isolated from 
entirely different contexts, microvillus-derived ECVs and matrix ECVs share a common 
function in biochemically conditioning their local microenvironment. In the former case, 
dephosphorylation of LPS by alkaline phosphatase significantly reduces LPS toxicity 
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(Poelstra et al., 1997); in the latter, production of inorganic phosphate is critical for 
proper assembly of normal bone. In both systems, however, the ability to produce ECVs 
with specific, enriched catalytic activity is needed for maintaining homeostasis.
 Distribution of catalytic activity is not the only function of EVCs in bone, however, 
as Aliotta et al discovered that marrow cell phenotype is  altered by lung-derived ECVs 
through transfer of mRNA, aiding in recovery of lung tissue after injury (Aliotta et al., 
2007; Aliotta et al., 2010). This suggests that ECVs may be involved in regulating stem 
cell fate decisions during tissue repair by regulating gene expression.
Cardiovascular function
 In the cardiovascular system, circulating ECVs are released from virtually every 
cell type, including platelets, immune cells (van der Pol et al., 2012; Cicero, 2013), 
endothelial and vascular smooth muscle cells. In some cases, these vesicles have been 
shown to participate in the coagulation process (Cocucci et al., 2009), while other work 
revealed that cardiovascular ECVs can distribute HSP60 (Gupta and Knowlton, 2007). 
Waldenstrom et al “transfected” fibroblasts  with nucleic acid-containing ECVs isolated 
from adult mouse cardiomyocytes and demonstrated that genetic material from ECVs is 
transferred into target cells  where it induces changes in gene expression (Waldenstrom 
et al., 2012). Similarly, ECVs isolated from endothelial progenitor cells were able to 
stimulate vessel formation in culture and in a SCID mouse model, a process  dependent 
upon mRNA contained in the ECVs (Deregibus et al., 2007). In disease states, 
cardiovascular ECV production is upregulated, such as increased vesicle shedding 
observed in pre-atherosclerotic areas of the aorta (Bobryshev et al., 2012), and in cases 
of pro-thrombotic anemias  (Zwicker et al., 2011). Bastida et al described ECVs from 
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isolated human glioblastoma cells that contain factors  capable of activating clotting and 
platelet aggregation in vitro (Bastida et al., 1984); this work is consistent with earlier 
findings of ECVs isolated from human breast cancer and guinea pig hepatocarcinoma 
cells (Dvorak et al., 1983). A notable feature of glioblastoma ECVs is their potent 
activity, showing up to 10-fold greater procoagulant activity compared to cellular 
membrane fractions. Similar to other systems, this  finding demonstrates the utility of 
ECVs as distributors of a highly concentrated biological activity, allowing source cells to 
propagate the relevant signal in a targeted, efficient manner.
Nervous system function
 In neural tissue, exosomes are released from many cell types (Turola et al., 
2012), while ectosomes are shed by microglial cells (discussed above), neurons 
(Schiera et al., 2007), astrocytes (Bianco et al., 2005), and possibly oligodendrocytes 
(Turola et al., 2012; Verderio et al., 2012). Neuronal ECVs are enriched in FGF2 and 
VEGF, and could function in regulating angiogenesis (Schiera et al., 2007). Astrocytic 
ECVs carry IL-1β, implicating the organelles  in mediating immune responses, while an 
examination of oligodendrocyte-derived ECVs from patients with multiple sclerosis also 
suggests a role in pro-inflammatory signaling (Verderio et al., 2012). In 2006, Faure et al 
demonstrated the release of exosomes from neurons and astrocytes, which contained 
the GluR2 subunit of the glutamate receptor and other proteins (Faure et al., 2006). 
Though further work investigating the function of neuronal ECVs is  needed, this  and a 
subsequent study (Lachenal et al., 2011) suggest that neuronal-derived ECV play a 
regulatory role in the CNS for neuronal plasticity, perhaps by recycling or disposing of 
various receptors  or by transferring cargo proteins to receiving cells. ECVs were long 
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thought to be a general cellular “trash disposal,” an idea that was  mostly discarded as 
investigators discovered specific ECV functions. In the nervous  system, however, 
removing cellular detritus  is still considered a primary function of ECVs, and one that 
may play a significant role in maintaining homeostasis  by regulating receptors on the 
cell surface and removing pathology-inducing proteins targeted for degradation (Von 
Bartheld and Altick, 2011).
ECV function in disease
 Based on the broad contributions to normal physiology it is perhaps not 
surprising that ECVs play roles in numerous diseases (athlerosclerosis, coagulopathies, 
inflammation, infection and autoimmune disease (Thomas and Salter, 2010; Zwicker et 
al., 2011; Bobryshev et al., 2012; Dreux et al., 2012; Verderio et al., 2012)). However, 
here we focus on their role in cancer.
 A key finding that first implicated ECVs in cancer was the discovery that 
membrane vesicles shed from metastatic cells could induce lung metastasis (Poste and 
Nicolson, 1980). Early research on exosomes in the immune system (Chaput et al., 
2004) led to their eventual identification as vesicles secreted both from mouse and 
human tumor cells  and biofluids (Wolfers  et al., 2001; Andre et al., 2002). Although we 
still do not fully understand the differences  between ECV released from normal and 
cancer cells, recent work suggests that ECVs facilitate horizontal transfer of cargo and 
harness the activity of these cargoes to stimulate intracellular signaling pathways, 
promoting tumor progression (Muralidharan-Chari et al., 2010; Lee et al., 2011; Demory 
Beckler et al., 2012). Although we focus on protein cargo of ECVs in our discussion 
below, it is becoming increasingly apparent that these vesicles contain DNA and RNA, 
77
which may also confer important pro-neoplastic effects  (Valadi et al., 2007; Skog et al., 
2008; Hong et al., 2009; Pisetsky et al., 2011).
 Oncogenes represent an important class of active ECV cargoes that modulate 
recipient cells. Tissue transglutaminase (tTG)-containing ECVs purified from cancer 
cells induced NIH-3T3 cell survival and anchorage-independent growth, effects  that 
were linked to transfer of tTG via ECVs. Moreover, exosomes purified from colon cancer 
cells transfer mutant G13D KRAS and induce anchorage-independent growth and 
colony formation in 3D collagen matrix, further suggesting oncogene-containing 
exosomes promote cancer-related phenotypes (Demory Beckler et al., 2012). 
Additionally, treatment of mildly aggressive glioma cells with EGFRvIII-containing ECVs 
increased observed levels of EGFRvIII in these cells, which may be partly responsible 
for the observed increases in VEGF production and anchorage-independent growth of 
recipient cells (Al-Nedawi et al., 2008). Not surprising, given the variety of cargo and 
roles in intercellular communication, it seems that in addition to promoting cancer 
phenotypes, ECVs also carry tumor suppressors. A recent study showed functional 
PTEN in exosomes purified from fibroblast cells and treatment of cells with these 
exosomes reduced cellular proliferation (Putz et al., 2012). Combined, these data 
provide strong support for ECVs as vehicles for protein cargo transfer to recipient cells, 
allowing for promotion and suppression of tumor-related phenotypes.
 In addition to inducing features  of tumor initiation, data also indicate a role for 
ECVs in promoting angiogenesis, invasion, and metastasis. ECVs contain a wide 
variety of pro-metastatic cargo, including insulin-degrading enzyme, matrix 
metalloproteinases, tetraspanins, heat shock proteins, plasminogen, integrin family 
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members, and growth factors, (VEGF and FGF) (Graner, 2011; D'Souza-Schorey and 
Clancy, 2012). Pro-angiogenic effects  of ECVs include enhanced endothelial cell tubule 
formation and vascularization of in vivo Matrigel plugs (Hood et al., 2009; Mineo et al., 
2012). Cathepsin B-containing ECVs and EGFR ligand-containing exosomes are two 
examples of ECVs that elicit recipient cell invasion in vitro (Giusti et al., 2008; 
Higginbotham et al., 2011). Luga et al. recently reported that exosomes secreted from 
fibroblasts  enhance breast cancer cell motility and metastasis, a mechanism that was 
suggested to require exsosome association with Wnt11 and activation of recipient 
breast cancer planar cell polarity proteins (Luga et al., 2012). This study provides 
additional support for the cross-talk of stroma and tumor and implicates stromal 
fibroblast ECVs with cancer progression. The identity of cargoes packaged in ECVs and 
their ability to induce invasion both support a role for these vesicles in promoting 
metastatic phenotypes.
 Several key in vivo studies  have demonstrated the ability of ECVs to prime 
metastatic niches. Melanoma exosomes selectively home to and prime sentinel lymph 
nodes for melanoma cell metastasis  (Hood et al., 2011). Similarly, pretreatment of mice 
with melanoma exosomes results in accelerated lung metastasis (Liu et al., 2010). 
Finally, it was recently reported that melanoma exosomes reprogram bone marrow-
derived cells to a more pro-vasculogenic phenotype that supports  enhanced tumor 
growth and metastasis (Peinado et al., 2012). Together, these reports strongly indicate 
that ECVs act to enhance metastatic properties of recipient cells. Future studies are 
needed, however, to identify the mechanisms by which ECVs exert these actions.
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Common themes and conclusions
 Despite the diverse physiological contexts highlighted above, ECV functions 
generally partition into one of four categories: regulation of gene expression, induction 
of signaling, distribution of catalytic activity, and disposal of cellular ‘trash’ (Fig. 5-1). 
Even more broadly, ECVs serve to protect, concentrate, or remove cargo. Genetic 
material must be protected from degradation as it is  transported from source to target 
cell. Ligands or receptors may need to be concentrated in order to efficiently activate a 
signaling cascade, while catalytic activity may be enhanced by concentrating an 
enzyme on the surface of an ECV. Thus, ECVs are highly adaptable cargo-carrying 
platforms. 
As discoveries from the past decade have demonstrated the near-ubiquity of 
ECVs, several new areas of investigation will be important for developing a full 
understanding of these organelles. More detailed studies of exosome and ectosome 
formation will provide much needed clarity into the distinctions between these two 
pathways. Moreover, very little is  known about how ECVs are captured by recipient/
target cells. Initial studies implicate specific lipids (e.g. phosphatidylserine) and integrins 
in this process but the details are only beginning to come into focus (Deregibus et al., 
2007; Iglesias et al., 2012). Once precise mechanisms of ECV tethering, fusion and/or 
internalization with target cells have been established, understanding the transfer of 
enriched cargo molecules and downstream effects can be clarified.
 Translational applications of ECV biology are in their infancy, but include their 
use as therapeutic delivery vehicles and disease biomarkers. Recent studies  showed 
that stem cell ECVs are able to reprogram diseased cells (Iglesias et al., 2012), while 
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“custom” ECVs are capable of delivering experimental cargos (Mangeot et al., 2011). 
Other potential ECV-based therapies such as tissue repair and revascularization are 
being investigated (Lee et al., 2012). ECVs also serve as  attractive biomarkers  of 
disease progression. In addition to blood and serum, ECVs can be purified from other 
biofluids such as urine (Dear et al., 2012) and their cargo composition and rate of 
production is altered during various pathologies. However, a better understanding of 
ECV formation, uptake and function is needed to expand current studies  of ECVs as 
therapeutic delivery systems (Mangeot et al., 2011; Lee et al., 2012), to tailor synthetic 
ECVs for treatment of disease, or to use these organelles as biomarkers.
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CHAPTER VI
THE ENTEROCYTE BRUSH BORDER ACTS AS A BARRIER TO EPEC ATTACHMENT
Introduction
 For pathogens that penetrate the inner mucus layer covering enterocytes  in vivo, 
the brush border is  the first cellular structure encountered (McGuckin et al., 2011). 
Ultrastructural analysis of EPEC attachment and effacement have found this process to 
be comprised of two primary steps. Following initial contact with enterocytes, EPEC first 
sink into the brush border by ~30 minutes, then form A/E lesions and develop pedestals 
(Dean et al., 2006). The first step is mediated by Tir and intimin, the second, by Map 
and EspF (Dean et al., 2006). Attachment and effacement invariably follows from 
infection by WT EPEC. Mechanisms underlying EPEC virulence are highly adapted to 
hijack host cell machinery, and ultimately enterocytes are unable to prevent intimate 
bacterial attachment. However, based on the two-step process of attachment described 
above, as well as  the highly ordered and tightly packed nature of the brush border, we 
speculated that the brush border could function as a physical barrier to EPEC 
attachment by slowing, though not entirely preventing the A/E process. We 
hypothesized that disheveled or immature brush borders (i.e. those without normal 
microvillar packing and density) would be more susceptible to EPEC infection, as 
bacteria would be able to bypass initial interactions with microvilli and more readily 
make direct contact with the enterocyte apical surface.
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Results
Bacterial attachment increases in the absence of PCDH24
 A key regulator of brush border formation and maintenance of microvillar length 
and packing is the adhesion molecule protocadherin-24 (PCDH24). Ongoing work in our 
lab has shown that microvilli are connected near their distal tips by a web of inter-
microvillar links comprised of PCDH24/Mucin-like protocadherin (MLPCDH) 
heterodimers (Crawley et al., submitted). Microvillar packing is defective in the absence 
of PCDH24, and the precise microvillar length regulation seen in WT enterocytes is also 
lost. Thus, we chose to utilize shRNA mediated knockdown of PCDH24 in Caco-2BBE 
cells as a model for investigating the consequences of defective brush border structure 
on EPEC attachment.
 We grew cells on coverslips for 14 d post-confluency, a time point at which 
scramble shRNA control cells have formed a well-developed, though not fully packed 
brush border. At this  same time point, the brush borders of PCDH24 KD cells  lag 
significantly behind their control counterparts. Two weeks post-confluence represents a 
developmental stage where inherent differences between the two cells lines will be 
maximized. PCDH24 KD brush borders  are disheveled and irregular, with fewer 
microvilli than in control cells (Crawley et al., submitted). At 14 d, we added EPEC to the 
coverslips, and incubated the cells with bacteria for 1 and 3 hrs. Cells were fixed and 
stained with phalloidin to label the actin cytoskeleton and an α-Lipid A antibody to label 
EPEC. We subsequently imaged the coverslips and counted the number of bacteria 
adhered per unit area. Following a 3 hr incubation, the number of EPEC, the number of 
microcolonies, and the average microcolony area increased on PCDH24 KD cells (Fig. 
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6-1A-C). At one hour, the number of EPEC counted on Caco-2BBE monolayers  increased 
by an average of 25% in the absence of PCDH24 (Fig. 6-1D). In samples fixed three 
hours following infection, the absence of PCDH24 caused a ~20% increase in the 
number of attached bacteria (Fig. 6-1D).
EPEC attachment is inversely proportional to brush border maturity
 A disordered brush border caused by the absence of PCDH24 leads  to increased 
bacterial attachment. We hypothesized that the brush border of an undifferentiated or 
partially differentiated enterocyte, with clusters of microvilli of variable length and gaps 
between clusters, would be similarly susceptible to infection. To further investigate the 
relationship between brush border maturity and bacterial attachment, we grew 
Caco-2BBE cells on glass coverslips and infected them with EPEC at 3 d intervals over 
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Figure 6-1: Absence of PCDH24 increases bacterial attachment to enterocytes
(A) Total number of EPEC attached per unit area in control  and PCDH24KD Caco-2BBE cells following 3 hr 
incubation. (B) Total number of bacterial microcolonies per unit area after 3 hr. (C) Average area of EPEC 
microcolonies on control and PCDH24KD cells after 3 hr. Larger microcolonies indicates the bacteria 
reached intimate attachment earlier, allowing for growth and division. (A-C) example of representative 
experiment. (D) Relative number of EPEC attached to confluent monolayers of scramble and PCDH24 
cells at 1 and 3 hr; average of three separate experiments. p > 0.05
the course of differentiation. Following one hour incubation with bacteria, the cells were 
fixed and stained as before, imaged, and EPEC quantified. Consistent with our 
hypothesis, the number of bacteria per unit area decreased as differentiation 
progressed and microvilli packed together to form a well-ordered brush border (Fig. 
6-2A-C). At one day post-confluency, when microvilli are short, dispersed, and few in 
number, an average of ~0.85 bacterial cells per 10,000 µm2 attached to monolayers 
(Fig. 6-2D). By two weeks post-confluency, the number of bacteria adhered decreased 
by 2-fold and remained ~0.3 bacteria per 10,000 µm2 during the final week. As 
discussed above, polarization of Caco-2BBE cells on glass coverslips occurs over 
approximately three weeks. Expression of PCDH24 increases with, and helps to 
regulate formation of the brush border (Fig. 6-2D). By the end of the second week of 
polarization, gaps between clusters  of microvilli have begun to close and microvillar 
length becomes consistent across the surface of the cell. The decline in bacterial 
attachment during the first two weeks and subsequent minima maintained through the 
remaining time, could represent an optimal microvillar density for inhibiting bacterial 
contact with the apical cell surface by forming a “chain-link fence” to impair bacterial 
contact.
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Figure 6-2: Bacterial attachment decreases with brush border development
(A-C) Representative images of Caco-2BBE cells at increasing stages of differentiation on glass coverslips; 
(A) 1, (B) 10 and (C) 20 days post-confluency. As differentiation progresses, early EPEC attachment 
decreases, seen in the reduction of lipid A-labeled bacteria (arrowheads). Insets show progression of 
brush border maturation at higher magnification. (D) PCDH24 expression increases with brush border 
development, inversely proportional to the number of EPEC attached following 1 hr incubation.
Conclusions
 These results  demonstrate the importance of a well-ordered brush border for 
maintaing the integrity of the intestinal epithelial barrier. By simply breaking the normal 
packing of enterocyte microvilli, we have shown that alterations to brush border 
morphology leave enterocytes  more susceptible to EPEC infection. Tight junctions are 
critical for barrier function, preventing direct translocation of toxins and microbes to the 
underlying tissue through what would otherwise be gaps between cells. During infection, 
EPEC disrupt tight junctions, leading to breakdown of the epithelial barrier and 
subsequent fluid efflux (Weflen et al., 2009). Data shown above demonstrates  that the 
brush border also serves as a physical impediment to bacterial attachment. This 
finding places the brush border and tight junctions in a similar category as mechanical/
physical mechanisms of innate immunity, with the brush border likely working upstream 
of tight junctions. As the first contact point for pathogens, the brush border may function 
as a fence to slow attachment and limit activation of intracellular pathways leading to 
disruption of tight junctions. PCDH24, as  a regulator of microvillar length and packing 
density, is central to this feature. Increased variability between microvilli due to the 
absence or reduction of the adhesion molecule is associated with increased infection, 
including both early attachment and microcolony formation. Thus, brush border 
morphology is not only optimized for proper nutrient absorption, but also for maintaining 
gut homeostasis.
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CHAPTER VII
MICROVILLAR DYNAMICS DURING EPEC ATTACHMENT
Introduction
 It is  clear that EPEC is highly adapted to infect enterocytes  regardless of brush 
border maturity. Although the chain-link fence model of brush border function may allow 
enterocytes to reduce the rate of attachment and perhaps provide time for other 
defense mechanisms to be activated, it is not sufficient to ultimately prevent infection. 
EPEC pathogenicity is dependent upon the bacterium’s ability to rearrange the apical 
domain of enterocytes  through disruption of tight junctions, hijacking of cytoskeletal 
machinery, and effacement of the brush border (Dean and Kenny, 2009). Thus, another 
question that arises from studying interactions between pathogen and brush border is 
how the morphology of this domain is disrupted during attachment, and whether or not 
microvilli contribute in some way to the attachment process. The enterocyte brush 
border is  a highly ordered array of actin-based protrusions, the microvilli, which exhibit 
tight hexagonal packing. Over the course of the A/E process, which occurs on the order 
of hours, EPEC ablate the brush border and reduce the enterocyte apical membrane to 
a smooth surface save for pedestals. Although the events  surrounding later stages of 
intimate EPEC attachment and pedestal formation are well characterized, initial contact 
between a bacterial cell and the brush border have not been well studied. Additionally, 
limited temporal data for EPEC attachment and the A/E process  exists. SEM imaging 
has provided important insight into the ultrastructure of the early A/E process, but these 
studies lacked a true kinetic component as the samples were taken every 20 min 
(Phillips et al., 2000; Dean et al., 2006). More recently, confocal microscopy was used 
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to track the accumulation of actin at sites of attachment. However, this  study only 
included a quantification of actin signal to analyze the ability of EPEC BFP mutants  to 
form pedestals, and did not investigate the structural changes occurring on the host cell 
surface (Zahavi et al., 2011). Live cell imaging could therefore be utilized to reveal brush 
border and microvillar dynamics, such as elongation and effacement, during early EPEC 
attachment.
 The signaling cascade from Tir to Arp2/3 activation has been well characterized; 
however, to our knowledge a direct investigation as to the source of actin that is 
incorporated into pedestals has  not been undertaken. The assumption that free G-actin 
monomers, most likely released from profilin-mediated sequestration in the cytosol, are 
polymerized into nascent filaments by the activity of N-WASP and Arp2/3. However,  this 
model may be incomplete, as  Arp2/3 binds to the sides of existing F-actin and nucleates 
new daughter filaments at a 70° angle (Pollard et al., 2000). Therefore, proper formation 
of a branched actin network such as a bacterial pedestal requires the presence F-actin 
“templates.” In a polarized enterocyte, the brush border contains a huge population of 
such F-actin filaments  in the form of bundled microvillar actin. It is  intriguing to consider 
the idea that microvilli could in fact provide a source of pedestal actin. Disassembly of 
microvillar actin during effacement could increase the local concentration of free G-actin 
monomers available for re-polymerization into pedestals, while remaining fragments of 
microvillar actin filaments could serve as the necessary templates for Arp2/3.
 Despite the significant insight into the function of bacterial effector proteins − 
including EspF and intimin − in pedestal formation, and the importance of these 
molecules for microvillar elongation (Phillips et al., 2000; Shaw et al., 2005), no work 
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has yet elucidated a specific host cell mechanism by which elongation occurs. 
Additionally, seemingly peripheral parts of the A/E process, including microvillar 
elongation and effacement, have been noted as hallmarks of EPEC infection, but not 
studied in the context of their potential contributions to pedestal formation. In order to 
address these gaps, and to investigate the idea that microvilli could contribute to 
pedestal actin, we utilized time-lapse deconvolution microscopy to visualize bacterial 
attachment and associated ultrastructural changes, complemented by SEM imaging.
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Figure 7-1: Dynamics of pedestal formation and brush border flow during EPEC attachment
(A) Caco-2BBE cell  at t0, the point of first EPEC contact. Site of attachment shown by arrowhead. (B) 
Pedestal  formation begins within 3 min of initial bacterial contact; (C) mature pedestals develp in 10 min 
(13 min after initial contact). (D) The enterocyte brush border flows towards sites of EPEC attachment 
(arrowhead), and microvilli coalesce around the periphery of developing microcolonies as actin 
accumulates in pedestals. (E) Example of microvillar cluster folding into the edge of the microcolony; 
dashed arrow represents linescan taken for kymograph in right panel.
Results
Dynamics of the enterocyte brush border during early attachment
 To visualize EPEC attachment to IECs, we transiently transfected Caco-2BBE cells 
with a fluorescent protein-tagged version of the utrophin calponin homology domain 
(mCherry-Utr), which binds to F-actin without disrupting actin dynamics (Burkel et al., 
2007). Additionally, we transfected the cells  with GFP-PCDH24 both to label membrane 
and to promote brush border integrity. Activated EPEC were added to Caco-2BBE cells 
on glass bottom dishes and imaged at 10-20 sec intervals using deconvolution 
microscopy. By ~3 min following initial contact between EPEC and host cell, actin 
begins to accumulate underneath the bacterium, and ~10 min later a fully formed 
pedestal is  seen (Fig. 7-1A-C). EPEC attachment involves a series of steps in which the 
BFP helps mediate initial contact and then retracts, drawing the bacterium closer to the 
host cell surface (Zahavi et al., 2011). Injection of TIR, binding of its  ligand intimin, and 
activation of N-WASP and Arp2/3 mediated actin polymerization follow (Wong et al., 
2011). Ultrastructual analysis  demonstrated that EPEC begin to sink into the brush 
border within 5 min of attachment (Dean et al., 2006). Our live cell imaging data show 
that actin polymerization occurs on a similar time scale, although there may be a delay 
in vivo due to tighter microvillar packing than in cells used here.
 Remarkably, in addition to localized pedestal formation we also observed 
significant brush border dynamics across the surface of enterocytes within 5-10 min of 
initial attachment. In cells  with relatively tightly packed brush borders, microvilli 
clustered together, turned and folded towards the bacterium (Fig. 7-1D, E). Over the 
course of an hour, as  the A/E lesion expanded due to attachment and division of 
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additional bacteria, this directed flow occurred across the surface of the cell. Microvilli 
distal to the bacteria were drawn across the cell into the microcolony and subsequently 
effaced. As a result, the periphery of the lesion was surrounded by an expanding ring of 
microvillar membrane overlaying the disassembling actin bundles, while the center of 
the lesion was devoid of PCDH24 and actin was found exclusively in the pedestals (Fig. 
7-1D). From these time-lapse sequences, we conclude that EPEC attachment and 
brush border effacement is  not simply a matter of localized destruction of microvilli in the 
immediate vicinity of bacterial adhesion, but rather a dynamic process  in which the 
entire brush border is rearranged, coalescing at sites of attachment and then 
disassembling to allow for pedestal formation. This finding is consistent with the 
hypothesis that microvillar actin is used by EPEC to form pedestals. By initiating brush 
border flow, bacterial cells could recruit a large pool of microvillar F-actin to sites  of 
attachment, stockpiling the cytoskeletal protein for use in pedestal formation.
PCDH24 regulates brush border flow
 In addition to bulk flow of the brush border during attachment, we also observed 
events where individual microvilli elongate towards bacteria. These extensions likely 
represent the formation of previously described microvillar-like processes (MLP) 
(Bernet-Camard et al., 1996; Phillips  et al., 2000; Cleary et al., 2004; Shaw et al., 2005; 
Dean et al., 2013). However, imaging the dynamics of individual microvilli was difficult 
due to the high microvillar density in our cells. Because inter-microvillar adhesion is 
mediated by PCDH24 (Crawley et al., submitted), and we observed striking 
accumulation of PCDH24-GFP signal as microvilli coalesce around adhering EPEC, it is 
possible that the adhesion molecule was tying microvilli together to produce bulk flow. In 
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order to better investigate the dynamics of individual microvilli, we overexpressed a 
dominant-negative PCDH24-GFP construct (PCDH24-ΔEC1) in which deletion of the 
first extracellular domain prevents  formation of the PCDH24-MLPCDH heteromeric 
complex (Crawley, unpublished data). Similar to PCDH24 knockdown, expression of this 
construct reduced normal microvillar packing. PCDH24-ΔEC1 provided an excellent tool 
both to dissociate microvilli from each other and to increase the space between 
microvilli for better analysis of individual protrusions. Additionally, PCDH24-ΔEC1 limited 
brush border flow, seen in images where frames at 0 and 30 min attachment were 
overlaid (Fig. 7-2). Cells expressing PCDH24-GFP with high-density brush borders 
contracted over time, and the microvilli lost their distinct punctate appearance by 
condensing around sites of attachment (Fig. 7-2A, dashed regions). By contrast, while 
sites of attachment could be seen on PCDH24-ΔEC1-GFP expressing cells, the rest of 
the cell surface remained relatively unperturbed (Fig. 7-2B, dashed regions). Without 
brush border flow, the dynamics of individual microvilli on PCDH24-ΔEC1-GFP 
expressing cells became much more amenable to analysis.
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Microvilli elongate during early EPEC attachment
 Numerous examples of elongated microvilli contacting bacteria were observed 
using live cell microscopy on Caco-2BBE cells  expressing mCherry-Utr and PCDH24-
ΔEC1-GFP (Fig. 7-3A, B). These features resembled clusters of elongated microvilli in 
SEM images of cells  infected with EPEC for three hours (Fig. 7-3D), consistent with 
previous work describing MLP (Bernet-Camard et al., 1996; Phillips et al., 2000; Cleary 
et al., 2004; Shaw et al., 2005; Dean et al., 2013). Contrary to observations made by 
Phillips et al. (2000), however, we regularly observed microvillar elongation during the 
earliest stages of EPEC attachment, as well as at the later stages of microcolony 
formation (Fig. 7-3E, F). Furthermore, confocal microscopy of phalloidin-stained 
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Figure 7-2: PCDH24 regulates brush border flow
(A) Representative Caco-2BBE cell  expressing full-length PCDH24 shows signs of microvilli moving across 
the surface into sites of EPEC attachment (dashed regions), as well  as significant contraction of the cell 
circumference. (B) Both brush border flow and changes in apical cellular morphology are reduced in cell 
expressing dominant negative construct, PCDH24-ΔEC1. Note the lack of significant microvillar 
accumulation 30 min after attachment. Red = t0, green = t30 after initial attachment.
samples revealed that the protrusions, including those formed within 15’ of initial 
bacterial attachment are indeed actin-filled (Fig. 7-3E, F). This  finding suggests  that the 
formation of elongated microvilli is due to rapid actin polymerization stimulated by the 
presence of EPEC, rather than simply membrane tubules  that might occur if a lightly 
attached bacterium moved away from the site of initial adhesion and drew microvillar 
membrane out in a tether. We found that microvilli elongate at ~50nm/s (data not 
shown), a rate consistent with previous studies of actin polymerization both in solution 
and in cellular protrusions (Pollard and Mooseker, 1981; Argiro et al., 1985).
 Imaging of attachment events indicates that microvillar elongation is  a directed 
phenomenon with the distal tips of microvilli extending towards bacteria. In cells  infected 
with EPEC, rare examples of random microvillar elongation can be found; that is, 
microvilli will extend in the absence of a nearby bacterium. However, this  is likely due in 
some way to the presence of bacteria, possibly the result of released bacterial products 
such as outer membrane vesicles (Kuehn and Kesty, 2005), as uninfected cells showed 
very little evidence of microvillar elongation (data not shown). Additionally, elongation 
did not occur on cells incubated with 2 µm silica or polystyrene beads, demonstrating 
that this phenomenon is the result of a biochemical, rather than mechanical stimulus 
(data not shown). Microvilli within ~5 µm of an attachment event rotated and oriented 
their distal tips  towards the pathogen. Rapid elongation immediately followed until the 
tip of the microvillus contacted the bacterial cell or surrounding membrane. In some 
instances microvilli retracted, returning to original length almost instantaneously (Fig. 
7-3C, dashed lines). Retraction may be the result of an inability of the protrusion to bind 
the bacterium, although the mechanisms involved are unknown and should be the focus 
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of future studies. Over time, productive microvillar binding events accumulated, leading 
to formation of a web of protrusions radiating between the bacterium host cell surface 
(Fig. 7-3A, right panel, Fig. 7-3D). Remarkably, we also noted instances of microvillar 
elongation occurring towards bacteria attached to a neighboring cell (Fig. 7-3B). Thus, 
EPEC does not have to be attached to stimulate elongation, further suggesting that it is 
a factor released from bacteria, rather than the bacteria themselves, stimulating this 
response.
 Where brush border flow might be used by bacteria to recruit actin to sites of 
attachment, stimulated - and directed - microvillar elongation could allow EPEC to tether 
individual host cell protrusions, pulling them into place for repurposing of the underlying 
F-actin. Intriguingly, preliminary data from our lab, along with previously published work, 
indicates that a functional BFP is required for microvillar elongation. In confocal images, 
BFP filaments were seen linking EPEC with microvilli, and retraction of BFP is known to 
draw the bacterium into close contact with the host cell surface (Cleary et al., 2004; 
Zahavi et al., 2011). It is interesting to speculate that attachment of BFP to a microvillus 
and subsequent retraction could exert enough force on the protrusion to stimulate 
elongation, and future studies  should focus on the interaction between EPEC adhesion 
molecules such as BFP and microvilli.
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Figure 7-3: Rapid microvillar elongation occurs during all stages of EPEC attachment
(A) Microvilli elongate towards adhering EPEC. Elongation occurs at a rate of ~50nm/s, and terminates 
when the microvillar tip (arrowheads) contacts the bacteria or the surrounding pedestal. (B) Protrusion 
from cell  shown in (A) extends towards bacterium attached to neighboring cell, demonstrating direct 
contact between EPEC and host cell  is not required to stimulate elongation. Dashed oval indicates 
location of EPEC. (C) Example of two microvilli elongating simultaneously towards bacteria, then 
retracting. Boxed region in upper panels indicates region used for time lapse montage in bottom panel. 
Dashed lines in montage indicate the microvillar elongation. (D) SEM image of microvillar elongation in 
Caco-2BBE cells following 3 hr incubation with EPEC. (E, F) Confocal image of microvillar elongation in 
Caco-2BBE cells following 15 min (E) and 3 hr (F) incubations with EPEC, showing elongated processes 
are actin-based and therefore likely true microvilli. Time stamps in (A, B, C) indicate time elapsed from 
first bacterial contact.
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Figure 7-4: Microvilli coalesce and incorporate into developing pedestals
(A) As pedestals form, microvilli  coalesce around bacteria in a “hand-of-doom” structure. Three examples 
at varying stages in boxes 1-3. (B) In Caco-2BBE cells expressing mCherry-espin, microvillar coalescence 
is seen in real time.  As pedestal formation progresses, espin signal accumulates, indicating that parallel 
actin from merging microvilli  is incorporated into these nascent structures. Boxed region in upper panels 
indicates region used for montage. Images in montage at 1 min intervals.
Microvillar actin is incorporated into pedestals
 As discussed above, the major steps in the A/E process have been described 
using SEM and genetic manipulation of EPEC virulence factors and host cytoskeletal 
machinery. Our work points to a novel component of intimate EPEC attachment, 
wherein microvilli could be used by bacteria as a source of actin. To further elucidate 
potential contributions of brush border actin to pedestal formation, we again utilized a 
combination of SEM and live cell deconvolution microscopy to investigate physical 
interactions between EPEC and microvilli.
 If microvilli are incorporated into nascent pedestals, microvillar coalescence 
should be evident in micrographs of pedestal formation. Pedestals on Caco-2BBE cells 
have a characteristic bun-like morphology, cupping a bacterial cell on both sides along 
its long axis (Fig. 7-4A). This  structure is comprised of an actin network encased in 
spectrin and overlaid by cellular membrane (Ruetz et al., 2012). Our data showed that 
pedestals began to form soon after initial contact between bacterium and host cell, as 
we observed enrichment of actin surrounding EPEC by 3 min (Fig. 7-1A, B). By 2-4 hr, 
bacteria that adhered early on formed robust pedestals and went through several 
rounds of division, leading to establishment of microcolonies ((Dean et al., 2006), Fig. 
7-4A). In SEM images of monolayers incubated with EPEC for 3 hrs, we observed 
numerous examples of individual pedestals encasing the bacteria within a microcolony. 
While the overall morphology of these structures is consistent, we noted the presence of 
protrusions of varying length extending from the apical edge of many pedestals (Fig. 
7-4A, boxes 1-3). The diameter of these protrusions are consistent with that of microvilli. 
Some protrusions are only tens of nanometers long and appear to have coalesced into 
99
the underlying pedestal (Fig. 7-4A, boxes 2, 3) while others  are at least hundreds of 
nanometers (Fig. 7-4A, box 1) and are only partially engulfed. Although the analysis is 
limited by the static nature of the samples, these images suggest that microvilli 
surrounding bacteria do merge and coalesce into the pedestal wall. This is consistent 
with data described above, where brush border flow and microvillar elongation provide a 
mechanism for subsequent incorporation of microvillar actin into pedestals.
 We next repeated the live cell attachment assays, imaging Caco-2BBE cells 
expressing mCherry-tagged espin. An actin bundling protein, espin, stabilizes parallel 
actin bundles  and allows microvilli to reach > 5 µm (Loomis  et al., 2003). By using this 
construct, we hypothesized that the additional stability of the actin and the longer 
microvilli would allow us to more readily visualize microvillar interactions with bacteria, 
as well as determine how microvilli associate with each other during the attachment 
process. Consistent with data shown in (Fig. 7-1), we observed examples  of microvilli 
folding and contacting each other around bacteria. Even more striking, however, was 
the rapid accumulation of mCherry-espin signal in the characteristic oval shape of 
pedestals (Fig. 7-4B). This finding is noteworthy because espin bundles parallel actin, 
whereas pedestals are thought to be comprised of branched actin networks polymerized 
de novo (Bartles, 2000; Campellone, 2010). That is, the presence of espin in pedestals 
can be viewed as a proxy for the presence of bundled, parallel actin filaments, indicating 
that bacteria lesions are not comprised exclusively of a branched network. Espin does 
not bind G-actin monomers; therefore, the presence of this molecule suggests that 
either microvillar actin is incorporated into pedestals directly or newly polymerized actin 
filaments within a pedestal are immediately bundled by espin. Although this latter 
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possibility has not been tested directly, it is likely to be far less energetically favorable 
than the former. Direct incorporation eliminates the need to depolymerize microvillar 
actin, then utilize significant amounts of ATP to re-polymerize and bundle it into 
filaments within the pedestal. Furthermore, the transition microvilli make from 
independent protrusions to clusters to oval pedestals supports our hypothesis 
developed from SEM images that microvilli coalesce into these structures. To our 
knowledge, the finding that parallel actin bundles from microvilli are incorporated into 
nascent pedestals has not been described. Our data lead to an intriguing model where 
a second pathway of pedestal formation, based on the presence of a vast pool of pre-
formed actin filaments in the form of the brush border, functions in polarized epithelial 
cells in parallel to the canonical Arp2/3 mediated pathway.
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Figure 7-5: Espin overexpression alters the dynamics of pedestal formation
Highly cross-linked microvillar actin bundles in Caco-2BBE cells expressing mCherry-espin are correlated 
with altered rates of pedestal formation. (A) Cells forming pedestals following EPEC attachment. Left 
panel, example of fully formed pedestals after 1 hr; right panel, immature, though visible pedestal 
following 1 hr incubation. (B) Not all infected cells form pedestals, seen in the lattice-like pattern of 
microvilli without the characteristic oval pedestal shape. Yellow dashed regions indicate attachment sites.
Actin bundling inhibits pedestal formation
 Further imaging of mCherry-espin-expressing Caco-2BBE cells  revealed that not 
all cells  with EPEC contacting the brush border ultimately formed robust pedestals. In 
several instances, bacteria settled onto the elongated microvilli of espin-expressing cells 
and went through normal division over the course of a 1 hr assay. Despite the typical 
behavior of the bacteria, microvilli responded to a much lesser extent when compared to 
those expressing mCherry-Utr. Almost no elongation occurred, and though not entirely 
eliminated the reorientation of microvilli with their distal tips pointed towards bacteria 
was noticeably reduced. After 1 hr of incubation with EPEC, only half of cell analyzed 
(3/6) showed any signs of pedestal formation, of these two had reached normal stages 
of development (Fig. 7-4B, Fig. 7-5A, left panels). Additionally, the rate at which 
pedestals appeared varied widely, from 3 min (comparable to non-espin-expressing 
cells; Fig. 7-4B) to > 15 min (Fig. 7-5A, right panels). One possibility is that this 
variability is due to differences between cells in espin expression levels. However, 
plotting the onset of pedestal formation with the intensity of mCherry-espin in several of 
these cells revealed no obvious correlation (data not shown). In the remaining cells 
microvilli appeared to fold into a lattice-like structure, but no subsequent remodeling 
occurred and pedestal formation did not progress (Fig. 7-5B). We also co-transfected 
cells with mCherry-espin and GFP-βActin to confirm that this  result was not simply a 
matter of espin being excluded from some pedestals. Indeed, to the extent they formed 
at all, pedestals were always visible in both channels; none contained GFP-βActin only 
(data not shown).
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 These results are unexpected based on the canonical model of pedestal 
formation. Brush border effacement has traditionally been described as a hallmark of 
the A/E process, but very few studies have made a direct connection between 
disassembly of the actin-based microvillus  and emergence of the actin-based pedestal. 
Because the latter is thought to arise from de novo assembly of a branched actin 
network, the idea that existing filaments found in the microvillus could be repurposed for 
use in pedestals, thus providing an explanation for brush border effacement, has not 
been considered. Our data suggest that a pathway exists in parallel with Arp2/3-
mediated polymerization, where microvilli are recruited to sites of EPEC attachment, 
coalesce around the bacterium, and the underlying cytoskeleton is  remodeled into the 
dense network of pedestal actin. As this process proceeds, the overlying plasma 
membrane would be expected to remodel as the morphology of its cytoskeletal support 
changes. Indeed, the unusual “hand of doom” phenomenon seen in (Fig. 7-4A) appears 
to represent such an intermediate structure.
Pedestal formation is not dependent upon Arp2/3
 If our model of microvillar contributions to pedestal formation is  correct, we would 
expect that inhibition of the Arp2/3 pathway should not completely inhibit pedestal 
formation. Conversely, if de novo formation of a branched actin network occurs 
exclusively via Arp2/3-mediated polymerization, inhibition should prevent pedestal 
formation. To further investigate the possibility that microvilli may contribute to the EPEC 
attachment process independent of canonical pedestal formation, we took advantage of 
a recently developed small molecule inhibitor of the ArpC2 subunit of Arp2/3, called 
CK-666 (Nolen et al., 2009). Caco-2BBE monolayers grown for two weeks post-
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confluency were incubated 2 hr with DMSO control or CK-666. EPEC was then added in 
the presence of DMSO or the drug, and incubated for 3 hr. The cells  were fixed and 
stained with phalloidin to mark actin and α-LipidA to label EPEC. Intriguingly, the 
presence of CK-666 did not inhibit pedestal formation (Fig. 7-6A, B), nor was there a 
significant change in the number of bacteria adhered to the monolayer (Fig. 7-6C). We 
repeated the experiment using HeLa cells, which lack a brush border and instead form 
sparse dorsal filopodia. As with Caco-2BBE cells, pedestals still formed in the presence 
of CK-666 (data not shown). The number of bacteria (quantified here as the percentage 
of total area covered by bacteria) was reduced in drug-treated HeLa cells when 
compared to DMSO-treated controls (Fig. 7-6C). A second Arp2/3 inhibitor, CK-869, also 
did not prevent pedestal formation, although it caused significant morphological 
changes in HeLa cells (Nolen et al., 2009) (data not shown). In these cells, impaired 
pedestal formation due to a lack of Arp2/3 activity could be limiting intimate attachment, 
resulting in fewer bacteria counted after 3 hr. At the same time, pedestal formation is 
clearly not eliminated, which strongly indicates a secondary, though less efficient 
pathway exists that makes use of existing actin filaments. In other cell culture models, 
we have observed complete inhibition of lamellar dynamics upon treatment with 
CK-666, indicating the drug is  highly effective. It is  still possible, however, that CK-666 is 
not fully penetrant in HeLa cells, allowing some Arp2/3 activity and pedestal formation. 
In Caco-2BBE cells, multi-drug resistance transporters  could pump out CK-666, limiting 
its effectiveness and confounding the assays described above (Hirohashi et al., 2000). 
Therefore, further work using knockdown of Arp complex components is  needed to 
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confirm these results, and drug treatments such as  cytochalasin B should be tested to 
determine the effect altered actin dynamics have on pedestal formation.
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Figure 7-6: Arp2/3 inhibition does not prevent pedestal formation
(A) CK-666-treated Caco-2BBE cells infected with EPEC for 3 hr show normal pedestal formation 
compared to DMSO controls, indicating that Arp2/3 is not required for this process. (B) Fewer EPEC 
attach to HeLa cells treated with CK-666 than those treated with DMSO, and although some pedestals 
still form, they have lower actin levels than in controls. (C) Percent of total area covered by EPEC in 
Caco-2BBE and HeLa cells reveals the reduction in EPEC attachment in CK-666 treated HeLa cells, and 
the lack of response in Caco-2BBE. (D) Actin intensity in pedestals is reduced in HeLa cells, but not in 
Caco-2BBE, indicating inhibited pedestal formation in the former. Bars represent standard deviation
Conclusions
 Our work demonstrates the tug-of-war nature of the relationship between 
enterocyte and pathogen. Host cells appear to utilize the highly ordered brush border, 
regulated by inter-microvillar links comprised of PCDH24 and MLPCDH, to maintain a 
barrier against pathogens making intimate contact with the apical surface (Figs. 6-1, 
6-2). Conversely, the interconnected nature of brush border microvilli may provide a 
means for EPEC to collect F-actin in order to improve pedestal formation (Figs. 7-1, 
7-5). Enteric pathogens are well adapted to the environment of the intestinal mucosa, 
and therefore even an intact brush border will eventually be compromised by the 
bacterium. Despite this problem, slowing the adherent/invasive process to any extent is 
likely beneficial to the host, providing time for activation of other defensive pathways.
 From the standpoint of bacterial hijacking of enterocyte cellular machinery, we 
have also developed a new model of EPEC attachment that begins to connect 
microvillar effacement with pedestal formation. In this model, bacteria stimulate the flow 
of the brush border towards sites of attachment and cause elongation of microvilli, 
where the protrusions  coalesce and may be partially disassembled or severed before 
microvillar actin bundles are recycled into a nascent pedestal. Having such a 
mechanism in place could be energetically favorable, potentially avoiding the need for 
much of the ATP expenditure required to build a de novo actin network, as well as 
possibly increasing the overall efficiency of the process  by reusing existing cytoskeletal 
building blocks. Further work is  needed to elucidate 1) the mechanism by which brush 
border flow occurs, 2) actin binding and severing proteins involved in microvillar 
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elongation and recycling, and 3) the bacterial components responsible for stimulating 
these processes.
 There are significant challenges associated with these outstanding questions. It 
is  difficult to dissect attachment, as there is known redundancy and cooperatively 
among EPEC virulence factors, and thus many host cell pathways are perturbed 
simultaneously (Dean and Kenny, 2009). Furthermore, the difference between a 
defensive host cell response and the pathogenic activity of bacteria may be difficult to 
distinguish. For example, microvillar elongation may help stabilize bacteria on the 
surface during early attachment, but the absence of this  phenomenon does not 
eliminate pedestal formation in cells  without microvilli such as HeLa. Conversely, it is 
possible that elongation is  a defensive mechanism to prevent attachment or “sample” 
the pathogen in a manner similar to dendritic cells extending protrusions. Our 
observations that microvillar elongation can target EPEC attached to neighboring cells 
suggests this as a possibility. Like other host cell processes, elongation could be a 
normal cellular response that has been hijacked by a well-adapted pathogen to improve 
attachment. Historically, investigators have used EPEC mutants lacking various 
virulence factors  to elucidate pathways involved in infection. Similar studies are needed, 
along with genetic manipulation of enterocyte brush border proteins, in order to begin 
building a complete understanding of both the process of microvillar elongation and its 
purpose during EPEC attachment.
 It is interesting to note the paucity of information regarding microvillar effacement 
during infection, and the lack of a connection between this process and pedestal 
formation. Many of the early studies  investigating actin polymerization during pedestal 
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formation relied upon Xenopus egg extracts or non polarized cells, primarily HeLa but 
also including MEFs, COS1, and HEp-2 [for example (Campellone et al., 2002; 
Campellone and Leong, 2005)]. These cell lines are attractive due to their amenability to 
genetic manipulation and transfection. However, they lack a brush border, building 
instead a sparse network of microvilli or “dorsal filopodia” (Bohil et al., 2006). 
additionally, as part of the differentiation process, epithelial cells  utilized polarized 
trafficking pathways to segregate and maintain the apical and basolateral compartments 
(Cao et al., 2012). Although the Caco-2BBE cells used for live cell microscopy in the work 
described here were transiently transfected and thus not left in culture long enough to 
reach a fully polarized state, they do begin to assemble microvilli within hours of plating 
and thus rapidly acquire a significant apical network of parallel actin bundles. It is 
possible that the lack of true microvilli on the dorsal surface of non-polarized cells alters 
their interaction with A/E pathogens. In the absence of actin bundles, HeLa cells might 
be forced to rely on de novo actin polymerization through Arp2/3. Studies in these cells 
would therefore focus entirely on the Arp2/3 pathway, and subsequent work in intestinal 
epithelial cells would understandably target the same mechanism of pedestal formation. 
In the work described here, we focused on investigating microvillar dynamics during 
EPEC attachment, rather than directly targeting known signaling pathways. In this way, 
we have discovered that microvillar actin may play a role in the A/E process, and our 
data point to the possibility of an intriguing complementary pathway for pedestal 
formation. Future experiments will be needed to elucidate if and how these two 
pathways intersect, and their relative contributions to pedestal formation under 
physiological conditions.
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CHAPTER VIII
CONCLUSIONS AND FUTURE DIRECTIONS
 The work described here has revealed several novel aspects of enterocyte brush 
border function and dynamics during interactions  with intestinal pathogens. We 
demonstrated that microvilli of the intestinal brush border shed IAP-enriched vesicles 
into the intestinal lumen as a means to condition the gut environment and maintain 
homeostasis (Shifrin et al., 2012; Shifrin and Tyska, 2012). Importantly, through these 
studies we have found a mechanism to package and deliver IAP into the intestinal 
lumen. Concentrating the enzyme on vesicles, rather than releasing soluble IAP, may 
provide enterocytes a mechanism to increase its  efficacy in conditioning the lumenal 
environment. LV-bound IAP detoxifies LPS from several bacterial species through 
dephosphorylation, thereby reducing the pro-inflammatory potential of this  molecule 
(Fig. 3-1A, B; Fig. 3-3G). LVs also limit attachment of bacteria to the enterocyte (Fig. 
3-3). Because LVs coat the surface of lumenal microbes  (Fig. 3-1C, D), we hypothesize 
that LVs act as a physical buffer, blocking direct contact between a bacterium and 
enterocyte, thus preventing injection of virulence factors. However, this  model remains 
untested, and should be the focus  of future studies. Additionally, the precise nature of 
LV-microbe interactions remain unclear. It is possible that pathogens “infect” LVs via 
structures such as the BFP and the T3SS, with the vesicles serving as decoys for 
microvillar membrane. It is also possible that proteins on the surface of LVs, many of 
which are glycosylated, could simply stick to bacterial cell wall components  through 
charged interactions. These ideas, which are by no means mutually exclusive, should 
be tested through a combination of biochemistry (e.g. stripping the surface of LVs of 
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sugar moieties and/or proteins) and genetic manipulation of bacterial molecules. LVs 
also inhibit bacterial population growth in an IAP-independent manner, reducing the 
plateau phase of bacterial cultures and actually reducing the number of viable microbes 
(Figs. 3-4, 3-5). We have carried out preliminary mass spectrometry on LVs isolated 
from WT and myo1a KO mice. No obvious bactericidal proteins  were found in this 
analysis, but a more detailed investigation into the mechanism of LV-mediated bacterial 
death should be undertaken. Finally, although LV shedding is a constitutive process 
(Fig. 3-6), it is  upregulated in the presence of pathogenic bacteria (Fig. 3-7). 
Interestingly, we found that EPEC conditioned media was not sufficient to stimulate 
shedding. EPEC culture media contains cellular fragments and bacterial outer 
membrane vesicles (OMV), which carry virulence factors, promote bacterial infection, 
and stimulate host immune responses (Kuehn and Kesty, 2005). In light of the potency 
of OMVs, it is somewhat surprising that EPEC conditioned media did not increase LV 
shedding. One explanation is that a single treatment with this  media is  simply not 
enough to cause a detectable increase in LV production. That is, without constant 
release of new OMVs from live EPEC to replenish the existing pool, the stimulatory 
effect never reaches a threshold level in our cell culture model. Future studies could 
investigate this idea by adding fresh conditioned media at regular intervals, or by using 
a filter to separate intestinal epithelial cells from bacteria, thereby allowing only the 
OMVs through.
 In the absence of normal LV shedding in myo1a KO mice [Fig. 4-1 and 
(McConnell et al., 2009)], we found signs of chronic inflammation. These included 
increased cytokine production, increased numbers of goblet cells along the length of the 
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small intestine, and pockets  of eosinophil infiltration (Figs. 4-3, 4-4). Furthermore, these 
animals had altered gut bacterial populations, with shifts  at the family level that, though 
subtle, were consistent with those seen in previous studies of intestinal perturbation 
(Fig. 4-2, Table 4-1). Together, these results demonstrate that LVs  have a multi-faceted 
role in host defense and homeostasis, distributing catalytic activity into the lumen, 
inhibiting attachment of pathogens to the epithelial surface, and maintaining a normal 
intestinal microbiome.
 Both the work described here and the original characterization of the myo1a KO 
mouse found only subtle deficiencies in the intestine, but none were severe enough to 
cause gross abnormalities in the animal under normal laboratory housing conditions 
(Tyska et al., 2005). It is possible that the limited differences between WT and myo1a 
KO animals would be accentuated under conditions of intestinal distress. Therefore, 
future studies should induce perturbations to intestinal homeostasis using the murine 
pathogen Citrobacter rodentium, toxic bacterial compounds such as LPS, or DSS.
 We also attempted to directly assay inflammatory signaling through activation of 
the NF-kB signaling pathway by using the NF-kB-GFP-Luciferase (NGL) mouse 
developed at Vanderbilt (Everhart et al., 2006). Upon crossing these animals with our 
myo1a KO line, we hoped to use GFP and/or luciferase signal to compare levels  of 
inflammation to WT. Preliminary results were promising but not reproducible, and we 
also found significant variability in the apparent expression levels of the GFP and 
luciferase reporters  during homeostasis. In light of these confounding factors, we 
discontinued our studies using the NGL mouse model.
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 In the second part of this  work, we focused on direct interactions between an A/E 
pathogen and the brush border, and dynamics  associated with microvillar effacement 
during infection. We found that not only does the the brush border play an active role in 
host defense through the shedding of LVs, but it also serves as a physical barrier to limit 
bacterial attachment. Cells with normal microvillar packing density are less susceptible 
to bacterial attachment during the first few hours of infection (Figs. 6-1, 6-2). Throughout 
the literature on intestinal host-microbe interactions, barrier function of the mucosal 
layer has  been a primary focus, in particular the regulation of epithelial permeability by 
tight junctions. Our data describe a subset of epithelial barrier function, in which the 
morphology of the apical domain of enterocytes plays a role in this process  of limiting 
infection. As discussed in Chapter VI, even if enterocytes are unable to completely 
prevent infection when pathogens make contact, slowing the rate of infection may still 
be desirable. In the intestine, bacteria lacking intimate attachment are more likely to be 
eliminated by shear flow of lumenal contents  and peristalsis. A lag in intimate 
attachment could also allow for activation of other immune responses, without causing a 
full inflammatory cascade. 
 We also provide evidence that PCDH24 is a molecular regulator of brush border 
barrier function, thus showing the adhesion molecule to be important not only in 
enterocyte morphogenesis  (Fig. 6-1; Crawley et al., submitted), but also in maintenance 
of the apical domain and, by extension, intestinal homeostasis. Interestingly, our results 
using a dominant negative PCDH24 construct showed that this molecule may also be 
used indirectly by bacteria to collect actin at sites of attachment (Fig. 7-2). Live cell 
imaging revealed that brush border flow is a hallmark of the attachment process, and 
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appears to increase with greater microvillar packing density (Figs. 7-1, 7-2). We 
hypothesize that by tying microvilli together, PCDH24 provides a mechanism for force 
transduction across  the entire apical surface. As microvilli surrounding a bacterial cell 
elongate and coalesce, the inter-microvillar bonds could tug on neighboring protrusions, 
causing a domino effect towards the attachment site. By breaking inter-microvillar links 
formed by PCDH24, we were able to more carefully investigate the dynamics of 
microvillar elongation and coalescence, both events which we observed in SEM images. 
 An interesting component of host cell machinery that is  compromised during 
EPEC infection, which we did not investigate here, is  the motor protein myosin-2 
(myo2). It is activated during EPEC infection, causing disruption of the tight junctions by 
pulling on junction-associated actin (Yuhan et al., 1997). Contraction of the junctional 
actomyosin ring near the apical pole of enterocytes  could be partly responsible for 
changes in cellular circumference we described (Fig. 7-2). Myo2 is also found in the 
terminal web (Bement and Mooseker, 1996). Activation of the motor during infection 
could cause contraction of actin in and around the terminal web, which in turn would be 
expected to pull on microvillar actin rootlets  cross-linked to the terminal web 
cytoskeleton. Coupled with possible contributions of PCDH24 to force transduction 
between microvilli, this process could be an extremely effective mechanism for 
promoting bacterial-mediated apical remodeling of enterocytes  by drawing the brush 
border towards sites  of attachment. Live cell microscopy should be undertaken using 
the myo2 inhibitor blebbistatin, as well as  inhibition or knockdown of myo2 regulators 
such as myosin light-chain kinase to test this hypothesis.
113
 Using PCDH24-ΔEC1 transfected cells, we found that microvillar elongation is a 
directed phenomenon, in which actin polymerization is  stimulated by the presence of 
bacteria (Fig. 7-3). Microvilli also coalesce as they cluster around bacteria, and actin 
and membrane from the protrusions is  apparently remodeled into pedestals. SEM 
images show striking examples  of bacteria cupped by a structure we have termed the 
“hand of doom,” which appears to be a pedestal forming from the coalescence of 
microvilli (Fig. 7-4). Further support for a model of microvillar actin contributing to 
pedestals came from overexpression of the bundling protein espin (Loomis  et al., 2003). 
This  molecule is observed in pedestals, but also slows their formation or abolishes it 
altogether (Figs. 7-4, 7-5). Thus, parallel actin is  likely incorporated into pedestals, while 
the high degree of cross-linking in espin-stabilized microvilli inhibits  this  process. More 
broadly, our findings hint that actin binding proteins regulate the recycling process, an 
idea discussed further below. Finally, we tested this  novel mechanism by inhibiting 
Arp2/3, the actin-nucleating complex thought to be critical for pedestal formation (Wong 
et al., 2011). CK-666 inhibition of Arp2/3 did not prevent pedestal formation in Caco-2BBE 
cells, and while the number of attached EPEC and pedestal actin intensity were 
reduced in HeLa cells, bacterial lesions were still observed (Fig. 7-6). This led us to 
conclude that a lack of parallel actin bundles on the dorsal surface forces HeLa cells to 
primarily utilize the Arp2/3 pathway; inhibition of Arp2/3 therefore limits  pedestal 
formation.
 Throughout this work, we have investigated the relationship between host cell 
and pathogen by inverting the approach used in many previous studies. Rather than 
beginning with molecular pathways involved in EPEC infection and using microscopy as 
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a readout for genetic or biochemical manipulations, we instead started by imaging the 
attachment process in real time. In this  way, we were able to fill in some of the gaps in 
the field by providing kinetic data on dynamics of the enterocyte brush border and 
individual microvilli during the A/E process. For future studies, it will be important to  use 
the live cell analysis carried out in this  work as a foundation for biochemical and genetic 
studies in order to elucidate the molecular factors responsible for processes such as 
brush border flow, microvillar elongation, and microvillar coalescence.
 These proposed studies are not trivial, as  the host-pathogen interaction is 
extremely complex on a molecular level. The process of EPEC infection involves 
dozens of peptides and virulence factors supplied by the bacterium, which activate 
multiple host cell pathways. It is important to note that several of the steps, though part 
of the “canonical” EPEC signaling cascade, are not absolutely required for intimate 
attachment and pedestal formation under all circumstances. EspA-mediated adhesion 
can occur in the absence of BFP, although the rate of intimate attachment is reduced 
significantly (Cleary et al., 2004). Work in a cell culture and tissue explant models of 
EPEC attachment found that effacement is a two-step process, and at least three 
virulence factors play somewhat overlapping roles in microvillar effacement (Dean et al., 
2006). Map, EspF, Tir, and intimin work in concert to promote elongation and 
effacement, with EspF in particular being necessary for elongation in biopsy samples 
(Shaw et al., 2005; Dean et al., 2006). Our preliminary SEM data indicates that BFP is 
required for microvillar elongation in Caco-2BBE cells, while intimin is not, although onset 
of elongation is delayed and pedestals  do not form. In another example, PIP2-containing 
lipid rafts cluster at sites of attachment and recruit the actin-membrane adaptor protein 
115
A2. However, this process appears to be independent of Tir, and may represent an 
alternative pathway to cytoskeletal manipulation (Zobiack et al., 2002; Rescher et al., 
2004). Nck-deficient cells  still form pedestals in a Tir-dependent manner, and several 
putative Tir-binding partners  such as c-Src and tyrosine kinases have been described 
[reviewed in (Campellone, 2010)]. It is likely that these multiple parallel and/or 
compensatory pathways contribute to the heterogeneity of responses observed in 
cellular models  of EPEC attachment. To date, though many pieces of the attachment 
process, and many putative interactions between host and bacterial proteins have been 
elucidated [reviewed by Wong et al. (2011)], a complete map of the interactions 
between bacterial effectors  and host machinery does not exist. It would be interesting to 
utilize EPEC lacking some of the virulence factors  just described in live cell assays to 
better understand how these molecules alter host cell machinery in real time. Super-
resolution microscopy can also provide significant insight into the many aspects  of 
infection, including recruitment of host cell molecules by virulence factors to attachment 
sites, reorganization of lipid rafts  and associated proteins, and changes in structure or 
dynamics of pedestal formation in the absence of one or more bacterial proteins.
 Focusing on the host cell, another important avenue will be to investigate the 
actin-associated proteins  involved in microvillar elongation and effacement. Based on 
our findings with espin-overexpressing cells, as well as what is known about actin 
remodeling in other cellular protrusions, actin nucleating, binding and severing proteins 
are certainly involved in the process of microvillar elongation and recycling. The proteins 
espin, fimbrin, and villin localize to microvilli and are involved in regulation of the actin 
core (Bretscher and Weber, 1979, 1980; Bretscher, 1981; Bartles  et al., 1998). Villin and 
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fimbrin, along with another actin-binding protein ezrin, are recruited to sites of 
attachment and are thought to help regulate formation of pedestal actin (Goosney et al., 
2000). We have preliminary data showing that both fluorescent protein-tagged cofilin 
and fimbrin localize to pedestals, and in filopodia, the bundling protein fascin and the 
severing factor cofilin work synergistically to regulate actin bundles (Breitsprecher et al., 
2011). Microvillar length is regulated by a family of actin-binding proteins  called Eps8. 
Regulated by interactions with ezrin, the founding member, Eps8, bundles  actin 
filaments, while Eps8L1a caps them (Zwaenepoel et al., 2012). Eps8L1a localizes to 
microvillar tips, where growth of filaments occurs, and loss of Eps8L1a leads  to 
elongated microvilli (Zwaenepoel et al., 2012). The authors  of this work suggest that 
elongation is a result of uncontrolled actin polymerization in the absence of the Eps8L1a 
cap. This  could very likely parallel the process by which microvilli elongate during EPEC 
attachment, and Eps8L1a localization and function should therefore be assessed in this 
context.
 Additional clues  to the role microvillar actin might play in pedestal formation, and 
the process by which recycling occurs, can be found in work on other cellular 
protrusions. At the leading edge of migrating and spreading cells, Arp2/3 activity 
produces the lamellipodium, a dense network of branched actin. Filopodia, consisting of 
parallel actin bundles nucleated by formins, extend distally from lamellipodium to sense 
the surrounding environment (Mattila and Lappalainen, 2008). Intriguingly, work 
investigating mechanisms of lamellipodia formation found they are nucleated from 
filopodia (Guillou et al., 2008). Live cell imaging of spreading fibroblasts showed that 
lamellipodia emerge from established filopodia through a process the authors call 
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“filopodial swelling.” In the resulting model, parallel actin bundles of filopodia serve as 
“scaffold” for formation of the lamellipodial branched actin network, allowing the cell to 
feel out the surrounding environment then migrate forward. Microvilli and pedestals 
share many fundamental similarities, and microvillar coalescence and the “hand of 
doom” could mirror the process of filopodial swelling. That is, microvilli recruited to sites 
of EPEC attachment could serve as templates for formation of the pedestal, with Arp2/3 
binding to the sides of the existing filaments  and nucleating a branched network. In the 
absence of Arp2/3 activity, as with CK-666 treatment, the presence of parallel actin and 
its associated severing and bundling proteins may be sufficient to produce a 
rudimentary pedestal.
 Significant work needs to be done in order to investigate this emerging model of 
EPEC attachment to enterocytes. In particular, using genetic tools to manipulate the 
many actin-associated proteins discussed above will help develop a detailed molecular 
mechanism for brush border remodeling during early attachment. Doing so, however, 
will be extremely informative and lead to significant advances in our understanding not 
only of host-microbe interactions, but also the formation and maintenance of the 
enterocyte brush border.
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